• Principal Investigator
  • Female

Prof. dr. M. Prins

Position: Professor
Main activities: Research
Specialisation: Public Health and Epidemiology of Infectious Diseases
foto M. Prins is one of the AMC Principal Investigators
Focus of research:

Epidemiology of sexually transmitted and bloodborne infections, in particular HIV and HCV

Public Health

AMC themes: Infection & Immunity, Public Health & Epidemiology
Departments: Internal Medicine: Infectious diseases
Alberts CJ. HPV in minority populations: Epidemiology and vaccination acceptability. S.l.: s.n.; 2017. 327p. ISBN 978-90-77595-13-8 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij Public Health Service (GGD), -. (Promotor(s): Prins M; copromotor(s): Schim van der Loeff MF , Paulussen TGWM)
Alberts CJ, Michel A, Bruisten S, Snijder MB, Prins M, Waterboer T, Schim van der Loeff MF, High-risk human papillomavirus seroprevalence in men and women of six different ethnicities in Amsterdam, the Netherlands: The HELIUS study. PAPILLOMAVIRUS RES 2017;3:57-65 [PubMed]
Alberts CJ, van der Loeff MFS, Hazeveld Y, de Melker HE, van der Wal MF, Nielen A, El Fakiri F, Prins M, Paulussen TGWM, A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands. BMC PUBLIC HEALTH 2017;17 (1):220 [PubMed]
Bil JP, Prins M, Stolte IG, Dijkshoorn H, Heijman T, Snijder MB, Davidovich U, Zuure FR, Usage of purchased self-tests for HIV and sexually transmitted infections in Amsterdam, the Netherlands: results of population-based and serial cross-sectional studies among the general population and sexual risk groups. BMJ OPEN 2017;7 (9):e016609 [PubMed]
Booiman T, Wit FW, Girigorie AF, Maurer I, de Francesco D, Sabin CA, Harskamp AM, Prins M, Franceschi C, Deeks SG, Winston A, Reiss P, Kootstra NA, Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls. PLOS ONE 2017;12 (8):e0183357 [PubMed]
Booiman T, Wit FW, Maurer I, de Francesco D, Sabin CA, Harskamp AM, Prins M, Garagnani P, Pirazzini C, Franceschi C, Fuchs D, Gisslén M, Winston A, Reiss P, Kootstra NA [Contributors: Reiss P, Wit FWNM, Schouten J , Kooij KW, van Zoest RA, Elsenga BC, Janssen FR, Heidenrijk M, Zikkenheiner W, van der Valk M, Kootstra NA, Booiman T, Harskamp-Holwerda AM, Boeser-Nunnink B, Maurer I, Mangas Ruiz MM, Girigorie AF, Villaudy J, Frankin E, Pasternak A, Berkhout B, van der Kuyl T, Portegies P, Schmand BA, Geurtsen GJ , ter Stege JA, Klein Twennaar M, Majoie CBLM, Caan MWA, Su T, Weijer K, Bisschop PHLT, Kalsbeek A, Wezel M, Visser I, Ruhé HG, Franceschi C, Garagnani P, Pirazzini C, Capri M, Dall'Olio F, Chiricolo M, Salvioli S, Hoeijmakers J, Pothof J, Prins M, Martens M, Moll S, Berkel J, Totté M, Kovalev S, Gisslén M, Fuchs D, Zetterberg H, Winston A, Underwood J, McDonald L, Stott M, Legg K, Lovell A, Erlwein O, Doyle N, Kingsley C, Sharp DJ, Leech R, Cole JH, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, Burger D, de Graaff-Teulen M, Guaraldi G, Bürkle A, Sindlinger T, Moreno-Villanueva M, Keller A, Sabin C, de Francesco D, Libert C, Dewaele S]] , High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid. OPEN FORUM INFECT DIS 2017;4 (3):ofx108 [PubMed]
Borgdorff H, van der Veer C, van Houdt R, Alberts CJ, de Vries HJ, Bruisten SM, Snijder MB, Prins M, Geerlings SE, Schim van der Loeff MF, van de Wijgert JHHM, The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLOS ONE 2017;12 (7):e0181135 [PubMed]
Cole JH, Underwood J, Caan MWA, de Francesco D, van Zoest RA, Leech R, Wit FWNM, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CBLM, Winston A, Reiss P, Sharp DJ [Contributors: Schouten J , Kooij KW, Elsenga BC, Janssen FR, Heidenrijk M, Schrijver JHN, Zikkenheiner W, van der Valk M, Henderiks A, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Ruiz MMM, Booiman T, Girigorie AF, Villaudy J, Frankin E, Pasternak A, Berkhout B, van der Kuyl T, Stege JAt, Twennaar MK, Su T, Siteur-van Rijnstra E, Weijer K, Bisschop PHLT, Kalsbeek A, Wezel M, Visser I, Ruhé HG, Tembo L, Stott M, Legg K, Lovell A, Erlwein O, Doyle N, Norsworthy P, Garagnani P, Pirazzini C, Capri M, Dall'Olio F, Chiricolo M, Salviol S, Hoeijmakers J, Pothof J, Burger D, de Graaff-Teulen M, Bürkle A, Sindlinger T, Moreno-Villanueva M, Keller A, Prins M, Martens M, Moll S, Berkel J, Möller L, Visser GR, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, Gisslén M, Fuchs D, Zetterberg H, Libert C, Dewaele S, Guaraldi G]] , Increased brain-predicted aging in treated HIV disease. NEUROLOGY 2017;88 (14):1349-1357 [PubMed]
Coleman R, Prins M, Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe. EUROSURVEILLANCE 2017;22 (42):2-5 [PubMed]
Dijkstra M, de Bree GJ, Stolte IG, Davidovich U, Sanders EJ, Prins M, Schim van der Loeff MF, Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with men. BMC INFECT DIS 2017;17 (1):425 [PubMed]
Dijkstra M, de Bree GJ, Stolte IG, Davidovich U, Sanders EJ, Prins M, Schim van der Loeff MF, Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with men (vol 17, pg 425, 2017). BMC INFECT DIS 2017;17 (1):691 [PubMed]
Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K, The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative. CLIN INFECT DIS 2017;ahead of print [PubMed]
Fraser H, Martin NK, Brummer-Korvenkontio H, Carrieri P, Dalgard O, Dillon J, Goldberg D, Hutchinson S, Jauffret-Roustide M, Kåberg M, Matser AA, Matičič M, Midgard H, Mravcik V, Øvrehus A, Prins M, Reimer J, Robaeys G, Schulte B, van Santen DK, Zimmermann R, Vickerman P, Hickman M, Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe". J HEPATOL 2017;ahead of print [PubMed]
Ghosn J, Bayan T, Meixenberger K, Tran L, Frange P, D'Arminio Monforte A, Zangerle R, de Mendoza C, Krastinova E, Porter K, Meyer L, Chaix ML [Contributors: Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Zangerle R, Gill J, Lutsar I, Chêne G, Dabis F, Thiebaut R, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Meyer L, Boufassa F, Hamouda O, Meixenberger K, Bannert N, Bartmeyer B, Antoniadou A, Chrysos G, Daikos GL, Touloumi G, Pantazis N, Katsarou O, Rezza G, Dorrucci M, Monforte AdA, de Luca A, Prins M, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Muga R, Tor J, de Olalla PG, Cayla J, del Amo J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Sönnerborg A, Bucher HC, Günthard H, Scherrer A, Malyuta R, Murphy G, Porter K, Johnson A, Phillips A, Babiker A, Pillay D, Morrison C, Salata R, Mugerwa R, Chipato T, Price MA, Gilmour J, Kamali A, Karita E]] , CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus. J ANTIMICROB CHEMOTH 2017;72 (10):2862-2868 [PubMed]
Hoornenborg E, Achterbergh RCA, Schim van der Loeff MF, Davidovich U, Hogewoning A, de Vries HJC, Schinkel J, Prins M, van de Laar TJW, Men who have sex with men starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection: evidence from the Amsterdam PrEP study. AIDS 2017;-:- [PubMed]
Hoornenborg E, Achterbergh RCA, Schim van der Loeff MF, Davidovich U, Hogewoning A, de Vries HJC, Schinkel J, Prins M, van de Laar TJW, MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection. AIDS 2017;31 (11):1603-1610 [PubMed]
Hoornenborg E, Krakower DS, Prins M, Mayer KH, Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. AIDS 2017;31 (16):2179-2191 [PubMed]
Hoornenborg E, Prins M, Achterbergh RCA, Woittiez LR, Cornelissen M, Jurriaans S, Kootstra NA, Anderson PL, Reiss P, de Vries HJC, Prins JM, de Bree GJ, Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report. LANCET HIV 2017;4 (11):E522-E528 [PubMed]
Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, de Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A [Contributors: Mary Krause M, Leport C, Wittkop L, Reiss P, Wit F, Prins M, Bucher H, Gibb D, Amo JD, Thorne C, Kirk O, Pérez-Hoyos S, Hamouda O, Bartmeyer B, Chkhartishvili N, Antinori A, Monforte AdA, Prieto L, Rojo P, Soriano-Arandes A, Battegay M, Kouyos R, Tookey P, Casabona J, Miró JM, Konopnick D, Goetghebuer T, Sönnerborg A, Teira R, Garrido M, Haerry D, Raben D, Chêne G, Barger D, Schwimmer C, Termote M, Frederiksen CM, Friis-Møller N, Kjaer J, Salbøl Brandt R, Berenguer J, Bohlius J, Bouteloup V, Davies MA, Dunn D, Egger M, Furrer H, Guiguet M, Grabar S, Lambotte O, Leroy V, Lodi S, Matheron S, Monge S, Nakagawa F, Paredes R, Puoti M, Schomaker M, Smit C, Sterne J, Thiebaut R, van der Valk M, Wyss N]] , Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV MED 2017;18 (3):171-180 [PubMed]
Kooij KW, Vogt L, Wit FWNM, van der Valk M, van Zoest RA, Goorhuis A, Prins M, Post FA, Reiss P, Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. J INFECT DIS 2017;216 (6):622-631 [PubMed]
Merat SJ, van de Berg D, Bru C, Yasuda E, Breij E, Koostra N, Prins M, Molenkamp R, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T, Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus. J IMMUNOL METHODS 2017;ahead of print [PubMed]
Monge S, Jarrin I, Pantazis N, Mocroft A, Sabin CA, Touloumi G, van sighem A, Abgrall S, Dray-Spira R, Spire B, Castagna A, Mussini C, Zangerle R, Hessamfar M, Anderson J, Hamouda O, Ehren K, Obel N, Kirk O, de Monteynard LA, Antinori A, Girardi E, Saracino A, Calmy A, de Wit S, Wittkop L, Bucher HC, Montoliu A, Raben D, Prins M, Meyer L, Chene G, Burns F, del Amo J, Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe. AIDS 2017;31 (6):835-846 [PubMed]
Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K, Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. CLIN INFECT DIS 2017;64 (7):860-869 [PubMed]
Newsum AM, Ho CKY, Lieveld FI, van de Laar TJW, Koekkoek SM, Rebers SP, van der Meer JTM, Wensing AMJ, Boland GJ, Arends JE, van Erpecum KJ, Prins M, Molenkamp R, Schinkel J, The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands. AIDS 2017;31 (1):105-112 [PubMed]
Newsum AM, Schinkel J, van de Laar TJW, van der Meer JTM, Prins M, Spontaneous Clearance of Hepatitis C Virus Infection Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men. OPEN FORUM INFECT DIS 2017;4 (2):ofx090 [PubMed]
Newsum AM, Stolte IG, van der Meer JTM, Schinkel J, van der Valk M, Vanhommerig JW, Buvé A, Danta M, Hogewoning A, Prins M, Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM). EUROSURVEILLANCE 2017;22 (21):30540 [PubMed]
Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AMB, Gill J, Paraskevis D, Porter K, Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort. AIDS 2017;ahead of print [PubMed]
Prins M, Bruneau J, Estimates are not enough: scaling-up interventions to improve the health of people who inject drugs. LANCET GLOB HEALTH 2017;5 (12):e1162-e1163 [PubMed]
Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA, Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. INFECT GENET EVOL 2017;49:88-96 [PubMed]
Soodla P, Simmons R, Huik K, Pauskar M, Jõgeda EL, Rajasaar H, Kallaste E, Maimets M, Avi R, Murphy G, Porter K, Lutsar I [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Olson A, Cartier A, Fradette L, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Zangerle R, Gill J, Dabis F, Thiebaut R, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Meixenberger K, Bannert N, Bartmeyer B, Antoniadou A, Chrysos G, Daikos GL, Pantazis N, Katsarou O, Rezza G, Dorrucci M, Monforte AdA, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Sönnerborg A, Günthard H, Scherrer A, Malyuta R, Johnson A, Phillips A, Morrison C, Price MA, Giaquinto C, Grarup J, Kirk O, Bailey H, Volny Anne A, Panteleev A, Thorne C, Aboulker JP, Albert J, Asandi S, de Wit S, Reiss P, Gatell J, Karpov I, Ledergerber B, Møller C, Rakhmanova A, Rockstroh J, Sandhu M, Dedes N, Pizzuti D, Faggion S, Raben D, Schwimmer C, Scott M]] , HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay. HIV MED 2017;ahead of print [PubMed]
Steba GS, Koekkoek SM, Vanhommerig JW, Brinkman K, Kwa D, van der Meer JTM, Prins M, Berkhout B, Tanck M, Paxton WA, Molenkamp R, Schinkel J, DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users. J INFECT DIS 2017;ahead of print [PubMed]
Su T, Mutsaerts HJMM, Caan MWA, Wit FWNM, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB, Cerebral blood flow and cognitive function in HI-infected men with sustained suppressed viremia on combination antiretroviral therapy. AIDS 2017;31 (6):847-856 [PubMed]
Underwood J, Cole JH, Caan M, de Francesco D, Leech R, van Zoest RA, Su T, Geurtsen GJ, Schmand BA, Portegies P, Prins M, Wit FWNM, Sabin CA, Majoie C, Reiss P, Winston A, Sharp DJ, Gray and white matter abnormalities in treated HIV-disease and their relationship to cognitive function. CLIN INFECT DIS 2017;65 (3):422-432 [PubMed]
Vanhommerig JW, Bezemer D, Molenkamp R, van Sighem AI, Smit C, Arends JE, Lauw FN, Brinkman K, Rijnders BJ, Newsum AM, Bruisten SM, Prins M, van der Meer JT, van de Laar TJ, Schinkel J, Limited overlap between phylogenetic HIV and hepatitis C virus clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM. AIDS 2017;31 (15):2147-2158 [PubMed]
van Santen DK, van der Helm JJ, del Amo J, Meyer L, D'Arminio Monforte A, Price M, Béguelin CA, Zangerle R, Sannes M, Porter K, Bertus Geskus R, Prins M, Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014. J HEPATOL 2017;67 (2):255-262 [PubMed]
van Santen DK, van der Helm JJ, Lindenburg K, Schim van der Loeff M, Prins M, HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015. INT J DRUG POLICY 2017;47:95-101 [PubMed]
van Zoest RA, van der Valk M, Wit FW, Vaartjes I, Kooij KW, Hovius JW, Prins M, Reiss P, Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy. EUR J PREV CARDIOL 2017;24 (12):1297-1307 [PubMed]
[Contributors: Monge S, Mocroft A, Sabin A, Touloumi G, Sighem A, Abgrall S, Dray-Spira R, Spire B, Castagna A, Mussini C, Zangerle R, Hessamfar M, Anderson J, Hamouda O, Ehren K, Obel N, Kirk O, Antinori A, Girardi E, Saracino A, Calmy A, Wit S, Wittkop L, Bucher C, Montoliu A, Raben D, Prins M, Meyer L, Chene G, Burns F, Amo J, Judd A, Zangerle R, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause M, Ghosn J, Leport C, Wittkop L, Reiss P, Wit F, Prins M, Bucher H, Gibb D, Fätkenheuer G, Amo J, Obel N, Thorne C, Mocroft A, Kirk O, Stephan C, Pérez-Hoyos S, Hamouda O, Bartmeyer B, Chkhartishvili N, Noguera-Julian A, Antinori A, Monforte A, Brockmeyer N, Prieto L, Conejo P, Soriano-Arandes A, Battegay M, Kouyos R, Mussini C, Tookey P, Casabona J, Miró J, Castagna A, Konopnick D, Goetghebuer T, Sönnerborg A, Torti C, Sabin C, Teira R, Garrido M, Haerry D, Wit S, Miró M, Costagliola D, D'Arminio-Monforte A, Raben D, Chêne G, Barger D, Schwimmer C, Termote M, Campbell M, Frederiksen CM, Friis-Møller N, Kjaer J, Brandt R, Berenguer J, Bohlius J, Bouteloup V, Cozzi-Lepri A, Davies MA, Dorrucci M, Dunn D, Egger M, Furrer H, Guiguet M, Grabar S, Lambotte O, Leroy V, Lodi S, Matheron S, Miró J, Monge S, Nakagawa F, Paredes R, Phillips A, Puoti M, Rohner E, Schomaker M, Smit C, Sterne J, Thiebaut R, Valk M]] , Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?. HIV MED 2017;ahead of print [PubMed]
Alberts CJ, Vos RA, Borgdorff H, Vermeulen W, van Bergen J, Bruisten SM, Geerlings SE, Snijder MB, van Houdt R, Morré SA, de Vries HJC, van de Wijgert JHHM, Prins M, Schim van der Loeff MF, Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study. SEX TRANSM INFECT 2016;92 (8):611-618 [PubMed]
Bil JP, van der Veldt WM, Prins M, Stolte IG, Davidovich U, Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study. MEDICINE 2016;95 (39):e4910 [PubMed]
Cobos Jiménez V, Wit FWNM, Joerink M, Maurer I, Harskamp AM, Schouten J, Prins M, van Leeuwen EMM, Booiman T, Deeks SG, Reiss P, Kootstra NA [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J , Kooij KW, van Zoest RA, Elsenga BC, Prins M, Martens M, Moll S, Berkel J, Totté M, Visser GR, Kovalev S, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, Reis P, Janssen FR, Heidenrijk M, Zikkenheiner W, Boumans L, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Mangas Ruiz MM, Girigorie AF, Boeser-Nunnink B, Geerlings SE, Godfried MH, Goorhuis A, Hovius JWR, Nellen FJB, van der Meer JTM, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , ter Stege JA, Klein Twennaar M, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment. J INFECT DIS 2016;214 (2):216-225 [PubMed]
de Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, de Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D [Contributors: de Luca A, Flandre P, Descamps D, Castagna A, Cozzi-Lepri A, Churchill D, Dunn D, de Wit S, Brockmeyer NH, Garcia F, Imaz A, Kordossis T, Mussini C, Obel N, Roca B, Torti C, van Sighem A, Wensing A, Zangerle R, Wittkop L, Reiss P, Ceccherini-Silberstein F, Santoro MM, Perno CF, Günthard H, Schülter E, Zazzi M, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause MM, Ghosn J, Leport C, Wit F, Prins M, Bucher H, Gibb D, Fätkenheuer G, del Amo J, Thorne C, Mocroft A, Kirk O, Stephan C, Pérez-Hoyos S, Hamouda O, Bartmeyer B, Chkhartishvili N, Noguera-Julian A, Antinori A, Monforte AdA, Brockmeyer N, Prieto L, Conejo PR, Soriano-Arandes A, Battegay M, Kouyos R, Tookey P, Casabona J, Miró JM, Konopnick D, Goetghebuer T, Sönnerborg A, Sabin C, Teira R, Garrido M, Haerry D, Costagliola D, D'Arminio-Monforte A, Raben D, Chêne G, Judd A, Barger D, Schwimmer C, Termote M, Campbell M, Frederiksen CM, Friis-Møller N, Kjaer J, Brandt RS, Berenguer J, Bohlius J, Bouteloup V, Davies MA, Dorrucci M, Egger M, Furrer H, Guiguet M, Grabar S, Lambotte O, Leroy V, Lodi S, Matheron S, Monge S, Nakagawa F, Paredes R, Phillips A, Puoti M, Schomaker M, Smit C, Sterne J, Thiebaut R, van der Valk M, Wyss N, Aubert V, Battegay M, Bernasconi E, Böni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, de Tejada BM, Metzner K, Müller N, Nadal D, Nicca D, Pantaleo G, Rauch A, Regenass S, Rickenbach M, Rudin C, Schöni-Affolter F, Schmid P, Schüpbach J, Speck R, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R, Yerly S]] , Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J ANTIMICROB CHEMOTH 2016;71 (5):1352-1360 [PubMed]
Demirkaya N, Wit FWNM, van den Berg TJTP, Kooij KW, Prins M, Schlingemann RO, Abramoff MD, Reiss P, Verbraak FD [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J, Kooij KW, van Zoest RA, Elsenga BC, Prins M, Martens M, Moll S, Berkel J, Totté M, Visser GR, Kovalev S, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, Kootstra NA, Harskamp-Holwerda A, Maurer I, Ruiz MMM, Girigorie AF, van Leeuwen E, Janssen FR, Heidenrijk M, Zikkenheiner W, Boumans L, Wezel M, Jansen-Kok CSM, Geerlings SE, Godfried MH, Goorhuis A, Hovius JWR, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , Stege JAt, Twennaar MK, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study. INVEST OPHTH VIS SCI 2016;57 (3):1388-1397 [PubMed]
Fakoya I, Álvarez-del Arco D, Monge S, Copas AJ, Gennotte AF, Volny-Anne A, Göpel S, Touloumi G, Prins M, Barros H, Staehelin C, del Amo J, Burns FM, Advancing Migrant Access to Health Services in Europe (AMASE): Protocol for a Cross-sectional Study. JMIR RES PROTOC 2016;5 (2):e74 [PubMed]
Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ, Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden. INT J DRUG POLICY 2016;ahead of print [PubMed]
Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ, Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection. INT J DRUG POLICY 2016;ahead of print [PubMed]
Heijman T. From insight into STI testing strategies to sexual risk dynamics in MSM. S.l.: s.n.; 2016. 306p. ISBN 9789463320825 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij GGD Amsterdam, -. (Promotor(s): Prins M; copromotor(s): Davidovich E, Stolte IG)
Kooij KW, Schouten J, Wit FWNM, van der Valk M, Kootstra NA, Stolte IG, van der Meer JTM, Prins M, Grobbee DE, van den Born BJH, Reiss P, Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency. JAIDS-J ACQ IMM DEF 2016;73 (1):55-62 [PubMed]
Kooij KW, Wit FWNM, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra NA, Reiss P [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J , Kooij KW, van Zoest RA, Verheij E, Elsenga BC, Prins M, Schim van der Loeff MF , Martens M, Moll S, Berkel J, Totté M, Visser GR, May L, Kovalev S, Newsum A, Dijkstra M, Zaheri S, Hillebregt MMJ, Ruijs YMC, Benschop DP, El Berkaoui A, Zikkenheiner W, Janssen FR, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Booiman T, Ruiz MMM, Girigorie AF, Boeser-Nunnink B, Geerlings SE, Godfried MH, Goorhuis A, Hovius JWR, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Vugt M, de Bree G, van Eden J, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Bijsterveld M, Weijsenfeld A, Smalhout S, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, van der Velde N, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , Verbraak FD, Demirkaya N , Visser I, Schadé A, Nieuwkerk PT, Langebeek N, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals. J INFECT DIS 2016;214 (12):1817-1821 [PubMed]
Kooij KW, Wit FWNM, Schouten J, van der Valk M, Godfried MH, Stolte IG, Prins M, Falutz J, Reiss P [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J, Kooij KW, van Zoest RA, Elsenga BC, Prins M, Stolte IG, Martens M, Moll S, Berkel J, Möller L, Visser GR, Welling C, Zaheri S, Hillebregt MMJ, Gras LAJ, Ruijs YMC, Benschop DP, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Ruiz MMM, Girigorie AF, van Leeuwen E, Janssen FR, Heidenrijk M, Schrijver JHN, Zikkenheiner W, Wezel M, Jansen-Kok CSM, Geerlings SE, Godfried MH, Goorhuis A, Hovius JWR, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, Henderiks A, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Westerman AM]] , HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS 2016;30 (2):241-250 [PubMed]
Kooij KW, Wit FWNM, van Zoest RA, Schouten J, Kootstra NA, van Vugt M, Prins M, Reiss P, van der Valk M, Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine. AIDS 2016;30 (11):1771-1780 [PubMed]
Kovaleva A, Alberts CJ, Waterboer T, Michel A, Snijder MB, Vermeulen W, Coyer L, Prins M, Schim van der Loeff M, A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands - the HELIUS study. BMC INFECT DIS 2016;16 (1):502 [PubMed]
Mac Donald-Ottevanger MS, Vreden S, van der Helm JJ, van de Laar T, Molenkamp R, Dams E, Roosblad J, Codrington J, Hindori-Mohangoo AD, Prins M, Prevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname. VIROLOGY 2016;499:114-120 [PubMed]
Merat SJ, Molenkamp R, Wagner K, Koekkoek SM, van de Berg D, Yasuda E, Böhne M, Claassen YB, Grady BP, Prins M, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T, Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance. PLOS ONE 2016;11 (10):e0165047 [PubMed]
Möller LM, Brands R, Sluiter JK, Schouten J, Wit FW, Reiss P, Prins M, Stolte IG, Prevalence and determinants of insufficient work ability in older HIV-positive and HIV-negative workers. INT ARCH OCC ENV HEA 2016;89 (4):699-709 [PubMed]
Nakagawa F, van Sighem A, Thiebaut R, Smith C, Ratmann O, Cambiano V, Albert J, Amato-Gauci A, Bezemer D, Campbell C, Commenges D, Donoghoe M, Ford D, Kouyos R, Lodwick R, Lundgren J, Pantazis N, Pharris A, Quinten C, Thorne C, Touloumi G, Delpech V, Phillips A [Contributors: Nakagawa F, Ahmadou A, Amato-Gauci A, Brown A, Albert J, Bezemer D, Cambiano V, Campbell C, Casabona J, Commenges D, Cortina Borja M, Costagliola D, de Angelis D, Delpech V, de Luca A, Donoghoe M, Ford D, Garnett G, Ghys P, Hallett T, Kjaer J, Kouyos R, Lodwick R, Lundgren J, Pantazis N, Perez-Hoyos S, Pezzotti P, Pharris A, Quinten C, Salminen M, Smit C, Smith C, Sterne J, Supervie V, Thiebaut R, Thorne C, Tookey P, Touloumi G, van Sighem A, Phillips A, Burns F, Chêne G, Giaquinto C, Grarup J, Kirk O, Meyer L, Bailey H, Volny Anne A, Panteleev A, Porter K, Aboulker JP, Asandi S, Monforte AdA, de Wit S, Reiss P, del Amo J, Gatell J, Hamouda O, Karpov I, Ledergerber B, Hovedstaden R, Malyuta R, Møller C, Prins M, Rockstroh J, Rosinska M, Sandhu M, Cooper D, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Fradette L, Frost R, Cartier A, Raben D, Schwimmer C, Scott M]] , A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model. EPIDEMIOLOGY 2016;27 (2):247-256 [PubMed]
Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH, Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. OPEN FORUM INFECT DIS 2016;3 (1):ofw024 [PubMed]
Rodrigo C, Eltahla AA, Bull RA, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Estes C, Razavi H, Lloyd AR, Luciani F, Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia. J INFECT DIS 2016;214 (9):1383-1389 [PubMed]
Schouten J, Su T, Wit FW, Kootstra NA, Caan MWA, Geurtsen GJ, Schmand BA, Stolte IG, Prins M, Majoie CB, Portegies P, Reiss P [Contributors: Reiss P, Wit FWNM, van der Valk M, Schouten J , Kooij KW, van Zoest RA, Elsenga BC, Prins M, Stolte IG, Martens M, Moll S, Berkel J, Möller L, Visser GR, Welling C, Zaheri S, Hillebregt MMJ, Gras LAJ, Ruijs YMC, Benschop DP, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Ruiz M, Girigorie AF, van Leeuwen E, Janssen FR, Heidenrijk M, Schrijver JHN, Zikkenheiner W, Wezel M, Jansen-Kok CSM, Geerlings SE, Godfried MH, Goorhuis A, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, ter Stege JA, Twennaar MK, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Schmand BA, Geurtsen GJ , Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. AIDS 2016;30 (7):1027-1038 [PubMed]
Su T, Caan MWA, Wit FWNM, Schouten J, Geurtsen GJ, Cole JH, Sharp DJ, Vos FM, Prins M, Portegies P, Reiss P, Majoie CB, White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. AIDS 2016;30 (2):311-322 [PubMed]
Su T, Wit FWNM, Caan MWA, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB, White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS 2016;30 (15):2329-2339 [PubMed]
Tsui JI, Mirzazadeh A, Hahn JA, Maher L, Bruneau J, Grebely J, Hellard M, Kim AY, Shoukry NH, Cox AL, Prins M, Dore GJ, Lauer G, Lloyd AR, Page K, The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. DRUG ALCOHOL DEPEN 2016;169:156-162 [PubMed]
van den Boom W, Davidovich U, Heuker J, Lambers F, Prins M, Sandfort T, Stolte IG, Is Group Sex a Higher-Risk Setting for HIV and Other Sexually Transmitted Infections Compared With Dyadic Sex Among Men Who Have Sex With Men?. SEX TRANSM DIS 2016;43 (2):99-104 [PubMed]
Vanhommerig JW. Epidemiology and diagnosis of acute hepatitis C virus infection. S.l.: s.n.; 2016. 218p. ISBN 978-94-91602-42-9 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Prins M; copromotor(s): Schinkel CJ, Bruisten SM)
van Rooijen M, Heijman T, de Vrieze N, Urbanus A, Speksnijder A, van Leeuwen P, de Vries H, Prins M, Earlier Detection of Hepatitis C Virus Infection Through Routine Hepatitis C Virus Antibody Screening of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men Attending A Sexually Transmitted Infection Outpatient Clinic: A Longitudinal Study. SEX TRANSM DIS 2016;43 (9):560-565 [PubMed]
van Santen DK, de Vos AS, Matser A, Willemse SB , Lindenburg K, Kretzschmar MEE, Prins M, de Wit GA, Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands. PLOS ONE 2016;11 (10):e0163488 [PubMed]
van Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BJH, Reiss P, Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure. CLIN INFECT DIS 2016;63 (2):205-213 [PubMed]
[Contributors: Wyss N, Zwahlen M, Clifford G, Campbell M, Chakraborty R, Bonnet F, Chene G, Bani-Sadr F, Verbon A, Zangerle R, Paparizos V, Prins M, Dronda F, Le Moing V, Antinori A, Quiros-Roldan E, Mussini C, Miro JM, Meyer L, Vehreschild J, Obel N, Mocroft A, Brockmeyer N, Boue F, Sabin C, Spagnuolo V, Hasse B, de Wit S, Roca B, Egger M, Bohlius J]] , Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies. CLIN INFECT DIS 2016;63 (10):1373-1379 [PubMed]
[Contributors: del Amo J, Conejo PR, Sabin C, Warszawski J, Gennotte AF, Nadal D, Gibb D, Judd A, Thorne C, Olson A, Lodi S, Pantazis N, Termote M, Ledergerber B, Kristensen D, Brandt RS, Saidi Y, Burns F, Chêne G, Costagliola D, Giaquinto C, Grarup J, Kirk O, Meyer L, Bailey H, Anne AV, Panteleev A, Phillips A, Porter K, Aboulker JP, Albert J, Asandi S, Monforte AdA, de Wit S, Reiss P, Gatell J, Clínic FP, Bíomèdica R, Hamouda O, Karpov I, Lundgren J, Malyuta R, Møller C, Prins M, Rakhmanova A, Rockstroh J, Rosinska M, Sandhu M, Touloumi G, Cooper D, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Fradette L, Frost R, Cartier A, Raben D, Schwimmer C, Scott M, Collins IJ, Duff C, Gibb DM]] , Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future. EUROSURVEILLANCE 2016;21 (10):30162 [PubMed]
[Contributors: Rohner E, Schmidlin K, Zwahlen M, Chakraborty R, Clifford G, Obel N, Grabar S, Verbon A, Noguera-Julian A, Judd A, Collins IJ, Rojo P, Brockmeyer N, Campbell M, Chêne G, Prozesky H, Eley B, Stefan DC, Davidson A, Chimbetete C, Sawry S, Davies MA, Kariminia A, Vibol U, Sohn A, Egger M, Bohlius J, Tanser F, Vinikoor M, Macete E, Wood R, Stinson K, Garone D, Fatti G, Phiri S, Giddy J, Malisita K, Fritz C, Hobbins M, Kamenova K, Fox M, Technau K, Zangerle R, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause MM, Ghosn J, Leport C, Wittkop L, Reiss P, Wit F, Prins M, Bucher H, Sabin C, Gibb D, Fätkenheuer G, del Amo J, Thorne C, Mocroft A, Kirk O, Stephan C, Pérez-Hoyos S, Hamouda O, Bartmeyer B, Chkhartishvili N, Antinori A, Monforte ADA, Prieto L, Soriano-Arandes A, Battegay M, Kouyos R, Mussini C, Tookey P, Casabona J, Miró JM, Castagna A, Konopnick D, Goetghebuer T, Sönnerborg A, Torti C, Teira R, Garrido M, Haerry D, de Wit S, Costagliola D, Raben D, Barger D, Schwimmer C, Termote M, Frederiksen C, Friis-Møller N, Berenguer J, Bouteloup V, Cozzi-Lepri A, Davies MA, Dorrucci M, Dunn D, Furrer H, Guiguet M, Lambotte O, Leroy V, Lodi S, Matheron S, Monge S, Nakagawa F, Paredes R, Peters L, Phillips A, Puoti M, Schomaker M, Smit C, Sterne J, Thiebaut R, van der Valk M, Ly PS, Khol V, Sarun SM, Ung VB, Tucker J, Kumarasamy N, Saghayam S, Chandrasekaran E, Wati DK, Atmikasari LPP, Malino IY, Kurniati N, Muktiarti D, Fong SM, Lim M, Daut F, Yusoff NKN, Mohamad P, Razali KA, Mohamed TJ, Mohammed NADR, Nallusamy R, Chan KC, Sudjaritruk T, Sirisanthana V, Aurpibul L, Oberdorfer P, Hansudewechakul R, Denjanta S, Srisuk W, Kongphonoi A, Lumbiganon P, Kosalaraksa P, Tharnprisan P, Udomphanit T, Jourdain G, Bunupuradah T, Puthanakit T, Prasitsuebsai W, Chanthaweethip W, Chokephaibulkit K, Lapphra K, Phongsamart W, Sricharoenchai S, Truong KH, Du QT, Nguyen CH, Do VC, Ha TM, An VT, Nguyen LV, Khu DTK, Pham AN, Nguyen LT, Le ON, Sohn AH, Sethaputra C, Cooper DA, Law MG, Kariminia A]] , Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. CLIN INFECT DIS 2016;63 (9):1245-1253 [PubMed]
Alberts CJ, van Rooijen MS, Prins M, Pawlita M, Schim van der Loeff MF, Waterboer T, HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men. SEX TRANSM DIS 2015;42 (3):129-134 [PubMed]
Bil JP, Davidovich U, van der Veldt WM, Prins M, de Vries HJC, Sonder GJB, Stolte IG, What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study. AIDS 2015;29 (8):955-964 [PubMed]
de Vos AS, Prins M, Kretzschmar MEE, Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?. ADDICTION 2015;110 (6):975-983 [PubMed]
Gane E, Kershenobich D, Seguin-Devaux C, Kristian P, Aho I, Dalgard O, Shestakova I, Nymadawa P, Blach S, Acharya S, Anand AC, Andersson MI, Arendt V, Arkkila P, Baatarkhuu O, Barclay K, Ben-Ari Z, Bergin C, Bessone F, Blokhina N, Brunton CR, Choudhuri G, Chulanov V, Cisneros L, Croes EA, Dahgwahdorj YA, Daruich JR, Dashdorj NR, Davaadorj D, de Knegt RJ, de Vree M, Gadano AC, Gower E, Halota W, Hatzakis A, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarčuška P, Kostrzewska K, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Mossong J, Norris S, Nurmukhametova E, Oltman M, Oyunbileg J, Oyunsuren T, Papatheodoridis G, Pimenov N, Prins M, Puri P, Radke S, Rakhmanova A, Razavi H, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanchez Avila JF, Sanduijav R, Saraswat V, Schréter I, Shah SR, Shevaldin A, Shibolet O, Silva MO, Sokolov S, Sonderup M, Souliotis K, Spearman CW, Staub T, Stedman C, Strebkova EA, Struck D, Sypsa V, Tomasiewicz K, Undram L, van der Meer AJ, van Santen D, Veldhuijzen I, Villamil FG, Willemse S, Zuckerman E, Zuure FR, Prabdial-Sing N, Flisiak R, Estes C, Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2. J VIRAL HEPATITIS 2015;22 (Suppl. 1):46-73 [PubMed]
Grady BPX. Hepatitis C virus: risk factors and disease progression. S.l.: s.n.; 2015. 174p. ISBN 978-90-6464-873-1 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij Public Health Center Amsterdam, -. (Promotor(s): Prins M; copromotor(s): van Baarle D)
Grady BPX, Prins M, Rebers S, Molenkamp R, Geskus RB, Schinkel J, BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion. J VIRAL HEPATITIS 2015;22 (3):263-271 [PubMed]
Gras L, de Wolf F, Smit C, Prins M, van der Meer JTM, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB [Contributors: Kuijpers TW, Scherpbier HJ, Godfried MH, Reiss P, van der Poll T, Nellen FJB, Lange JMA, Geerlings SE, van Vugt M, Pajkrt D, Bos JC, van der Valk M, Wiersinga WJ, Goorhuis A, Hovius JWR, Lowe S, Oude Lashof A, Posthouwer D, Pronk MJH, Ammerlaan HSM, van der Ende ME, de Vries-Sluijs TEMS, Schurink CAM, Nouwen JL, Verbon A, Rijnders BJA, van Gorp ECM, van der Feltz M, Driessen GJA, van Rossum AMC, Branger J, Schippers EF, van Nieuwkoop C, van Elzakker EP, Groeneveld HP, Bouwhuis JW, Soetekouw R, ten Kate RW, Kroon FP, van Dissel JT, Arend SM, de Boer MGJ, Jolink H, Vollaard AM, Bauer MP, den Hollander JG, Pogany K, van Twillert G, Kortmann W, Cohen Stuart JWT, Diederen BMW, Leyten EMS, Gelinck LBS, Kootstra GJ, Delsing CE, Brinkman K, Blok WL, Frissen PHJ, Schouten WEM, van den Berk GEL, van Kasteren MEE, Brouwer AE, Veenstra J, Lettinga KD, Mulder JW, Vrouenraets SME, Lauw FN, van Eeden A, Verhagen DWM, Sprenger HG, Scholvinck EH, van Assen S, Bierman WFW, Wilting KR, Stienstra Y, Koopmans PP, Keuter M, van der Ven AJAM, ter Hofstede HJM, Dofferhoff ASM, Warris A, van Crevel R, Hoepelman AIM, Mudrikova T, Schneider MME, Ellerbroek PM, Oosterheert JJ, Arends JE, Wassenberg WWM, Barth RE, van Agtmael MA, Perenboom RM, Claessen FAP, Bomers M, Peters EJG, Geelen SPM, Wolfs TFW, Bont LJ, Richter C, van der Berg JP, Gisolf EH, van den Berge M, Stegeman A, van Vonderen MGA, van Houte DPF, Weijer S, el Moussaoui R, Winkel C, Muskiet F, Durand NN, Voigt R]] , Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals. JAIDS-J ACQ IMM DEF 2015;68 (5):536-542 [PubMed]
Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ, Recommendations for the management of hepatitis C virus infection among people who inject drugs. INT J DRUG POLICY 2015;26 (10):1028-1038 [PubMed]
Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J [Contributors: Page K, Bruneau J, Cox AL, Dore GJ, Grebely J, Hellard M, Lauer G, Kim AY, Lloyd AR, Maher L, McGovern BH, Prins M, Shoukry NH, Morris M, Hahn J, Shiboski S, Rice TM, Alavi M, Bouchard R, Evans J, Grady B, May L, Aneja J, Sacks-Davis R, Teutsch S, White B, Wells B, Zang G, Matthews G, Yeung B, Prince LE, Roy E, Bates A, Enriquez J, Chow S, McCredie L, Aitken C, Doyle J, Spelman T]] , Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLOS ONE 2015;10 (4):e0122232 [PubMed]
Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J [Contributors: Page K, Bruneau J, Cox AL, Dore GJ, Grebely J, Hellard M, Lauer G, Kim AY, Lloyd AR, Maher L, McGovern BH, Prins M, Shoukry NH, Morris M, Hahn J, Shiboski S, Rice TM, Alavi M, Bouchard R, Evans J, Grady B, Aneja J, Sacks-Davis R, Teutsch S, White B, Wells B, Zang G, Matthews G, Yeung B, Prince LE, Roy E, Bates A, Enriquez J, Chow S, McCredie L, Aitken C, Doyle J, Spelman T]] , Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study. J VIRAL HEPATITIS 2015;22 (9):708-717 [PubMed]
Hatzakis A, Chulanov V, Gadano AC, Bergin C, Ben-Ari Z, Mossong J, Schréter I, Baatarkhuu O, Acharya S, Aho I, Anand AC, Andersson MI, Arendt V, Arkkila P, Barclay K, Bessone F, Blach S, Blokhina N, Brunton CR, Choudhuri G, Cisneros L, Croes EA, Dahgwahdorj YA, Dalgard O, Daruich JR, Dashdorj NR, Davaadorj D, de Knegt RJ, de Vree M, Estes C, Flisiak R, Gane E, Gower E, Halota W, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarčuška P, Kershenobich D, Kostrzewska K, Kristian P, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Norris S, Nurmukhametova E, Nymadawa P, Oltman M, Oyunbileg J, Oyunsuren T, Papatheodoridis G, Pimenov N, Prabdial-Sing N, Prins M, Radke S, Rakhmanova A, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanchez Avila JF, Sanduijav R, Saraswat V, Seguin-Devaux C, Shah SR, Shestakova I, Shevaldin A, Shibolet O, Silva MO, Sokolov S, Sonderup M, Souliotis K, Spearman CW, Staub T, Stedman C, Strebkova EA, Struck D, Sypsa V, Tomasiewicz K, Undram L, van der Meer AJ, van Santen D, Veldhuijzen I, Villamil FG, Willemse S, Zuckerman E, Zuure FR, Puri P, Razavi H, The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. J VIRAL HEPATITIS 2015;22 (Suppl. 1):26-45 [PubMed]
Hoornenborg E, de Vries HJC, Schim van der Loeff MF , Davidovich U, Bil JP, Achterbergh RA, Fennema JS, Prins M, Pre-expositieprofylaxe voor preventie van hiv-transmissie: stand van zaken en Amsterdam PrEP-project.. HIV BULLETIN 2015;4:15-17
Hullegie SJ, Arends JE, Rijnders BJA, Irving WL, Salmon D, Prins M, Wensing AM, Klenerman P, Leblebicioglu H, Boesecke C, Rockstroh JK, Hoepelman AIM, Current knowledge and future perspectives on acute hepatitis C infection. CLIN MICROBIOL INFEC 2015;21 (8):797.e9-797.e17 [PubMed]
Kooij KW, Wit FWNM, Bisschop PH, Schouten J, Stolte IG, Prins M, van der Valk M, Prins JM, van Eck-Smit BLF, Lips P, Reiss P, Low bone mineral density in patients with well-suppressed HIV infection: association with body weight, smoking, and prior advanced HIV disease. J INFECT DIS 2015;211 (4):539-548 [PubMed]
Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M [Contributors: Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause MM, Leport C, Reiss P, Wit F, Prins M, Bucher H, Gibb D, Fätkenheuer G, del Amo J, Thorne C, Kirk O, Stephan C, Perez-Hoyos S, Hamouda O, Bartmeyer B, Chkhartishvili N, Noguera-Julian A, Antinori A, D'Arminio Monforte A, Brockmeyer N, Prieto L, Conejo PR, Soriano-Arandes A, Rauch A, Tookey P, Casabona J, Miro JM, Castagna A, Konopnick D, Goetghebuer T, Teira R, Garrido M, Haerry D, de Wit S, Costagliola D, D'Arminio-Monforte A, Raben D, Judd A, Barger D, Colin C, Schwimmer C, Termote M, Wittkop L, Campbell M, Friis-Moller N, Kjaer J, Brandt RS, Bohlius J, Bouteloup V, Cozzi-Lepri A, Dorrucci M, Egger M, Furrer H, Lambotte O, Lodi S, Matheron S, Miro J, Monge S, Nakagawa F, Paredes R, Phillips A, Puoti M, Smit C, Sterne J, Thiebaut R, van der Valk M, Wyss N]] , Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults. AIDS 2015;29 (2):193-200 [PubMed]
Matser AA. Sexually transmitted infections: unravelling transmission & impact. S.l.: s.n.; 2015. 304p. ISBN 978-90-6464-910-3 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij GGD Amsterdam, -. (Promotor(s): Prins M, Kretzschmar MEE; copromotor(s): Schim van der Loeff MF , Geskus RB)
Mocroft A, Lundgren J, Antinori A, Monforte AdA, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, de Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O [Contributors: Zangerle R, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause MM, Ghosn J, Leport C, Wittkop L, Reiss P, Wit F, Prins M, Bucher H, Gibb D, Fätkenheuer G, del Amo J, Obel N, Thorne C, Mocroft A, Kirk O, Stephan C, Pérez-Hoyos S, Hamouda O, Bartmeyer B, Chkhartishvili N, Noguera-Julian A, Antinori A, D'Arminio Monforte A, Brockmeyer N, Prieto L, Conejo PR, Soriano-Arandes A, Battegay M, Kouyos R, Mussini C, Tookey P, Casabona J, Miró JM, Castagna A, Konopnick D, Goetghebuer T, Sönnerborg A, Torti C, Sabin C, Teira R, Garrido M, Haerry D, de Wit S, Costagliola D, Raben D, Chêne G, Judd A, Barger D, Schwimmer C, Termote M, Campbell M, Frederiksen CM, Friis-Moller N, Kjaer J, Brandt RS, Berenguer J, Bohlius J, Bouteloup V, Cozzi-Lepri A, Davies MA, Dorrucci M, Dunn D, Egger M, Furrer H, Guiguet M, Grabar S, Lambotte O, Leroy V, Lodi S, Matheron S, Monge S, Nakagawa F, Paredes R, Phillips A, Puoti M, Schomaker M, Smit C, Sterne J, Thiebaut R, van der Valk M, Wyss N]] , Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. EUROSURVEILLANCE 2015;20 (47):7 30070-18 [PubMed]
Möller LM, Stolte IG, Geskus RB, Okuku HS, Wahome E, Price MA, Prins M, Graham SM, Sanders EJ, Changes in sexual risk behavior among MSM participating in a research cohort in coastal Kenya. AIDS 2015;29 (Suppl. 3):S211-S219 [PubMed]
Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M [Contributors: Page K, Bruneau J, Cox AL, Dore GJ, Grebely J, Hellard M, Lauer G, Kim AY, Lloyd AR, Maher L, McGovern BH, Prins M, Shoukry NH, Morris M, Hahn J, Rice TM, Alavi M, Bouchard R, Evans J, Grady B, Aneja J, Sacks-Davis R, Teutsch S, White B, Wells B, Zang G, Applegate T, Matthews G, Yeung B, van de Laar T, Erin Prince L, Roy E, Bates A, Enriquez J, Chow S, Park J, McCredie L, Aitken C, Bowden S, Higgs P, Tracy L, Briceno A]] , Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study. J INFECT DIS 2015;212 (9):1407-1419 [PubMed]
Saraswat V, Norris S, de Knegt RJ, Sanchez Avila JF, Sonderup M, Zuckerman E, Arkkila P, Stedman C, Acharya S, Aho I, Anand AC, Andersson MI, Arendt V, Baatarkhuu O, Barclay K, Ben-Ari Z, Bergin C, Bessone F, Blach S, Blokhina N, Brunton CR, Choudhuri G, Chulanov V, Cisneros L, Croes EA, Dahgwahdorj YA, Dalgard O, Daruich JR, Dashdorj NR, Davaadorj D, de Vree M, Estes C, Flisiak R, Gadano AC, Gane E, Halota W, Hatzakis A, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarčuška P, Kershenobich D, Kostrzewska K, Kristian P, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Mossong J, Nurmukhametova E, Nymadawa P, Oltman M, Oyunbileg J, Oyunsuren T, Papatheodoridis G, Pimenov N, Prabdial-Sing N, Prins M, Puri P, Radke S, Rakhmanova A, Razavi H, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanduijav R, Schréter I, Seguin-Devaux C, Shah SR, Shestakova I, Shevaldin A, Shibolet O, Sokolov S, Souliotis K, Spearman CW, Staub T, Strebkova EA, Struck D, Tomasiewicz K, Undram L, van der Meer AJ, van Santen D, Veldhuijzen I, Villamil FG, Willemse S, Zuure FR, Silva MO, Sypsa V, Gower E, Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J VIRAL HEPATITIS 2015;22 (Suppl. 1):6-25 [PubMed]
Simmons R, Malyuta R, Chentsova N, Medoeva A, Kruglov Y, Yurchenko A, Copas A, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Cartier A, Fradette L, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Kelleher T, Cooper D, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Zangerle R, Gill J, Lutsar I, Wittkop L, Dabis F, Thiebaut R, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Sambatakou H, Sipsas NV, Gogos CA, Pantazis N, Katsarou O, Rezza G, Dorrucci M, Monforte AdA, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Riise AMD, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Sönnerborg A, Günthard H, Rickenbach M, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Burns F, Giaquinto C, Grarup J, Kirk O, Bailey H, Anne AV, Panteleev A, Thorne C, Aboulker JP, Albert J, Asandi S, de Wit S, Reiss P, Gatell J, Karpov I, Ledergerber B, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Sandhu M, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Frost R, Raben D, Schwimmer C, Scott M]] , HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014. PLOS ONE 2015;10 (8):e0137062 [PubMed]
Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J [Contributors: Cox AL, Lauer G, McGovern BH, Prins M, Hahn J, Shiboski S, Mirzazadeh A, Alavi M, Bouchard R, Evans J, Grady B, Aneja J, Sacks-Davis R, Teutsch S, White B, Wells B, Applegate T, Matthews G, Yeung B, Schinkel J, Prince LE, Roy E, Bates A, Enriquez J, Chow S, McCredie L, Aitken C, Doyle J]] , A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs. J EPIDEMIOL COMMUN H 2015;69 (8):745-752 [PubMed]
Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MWA, Reiss P, Majoie CB, Schmand BA, Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS 2015;29 (5):547-557 [PubMed]
Thomas XV, Grady BPX, van der Meer JTM, Ho CK, Vanhommerig JW, Rebers SP, de Jong MD, van der Valk M, Prins M, Molenkamp R, Schinkel J, Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men. AIDS 2015;29 (17):2287-2295 [PubMed]
van den Boom W, Stolte IG, Roggen A, Sandfort T, Prins M, Davidovich U, Is anyone around me using condoms? Site-specific condom-use norms and their potential impact on condomless sex across various gay venues and websites in The Netherlands. HEALTH PSYCHOL 2015;34 (8):857-864 [PubMed]
Vanhommerig JW, Lambers FAE, Schinkel J, Geskus RB, Arends JE, van de Laar TJW, Lauw FN, Brinkman K, Gras L, Rijnders BJA, van der Meer JTM, Prins M, van der Meer JTM, Molenkamp R, Mutschelknauss M, Nobel HE, Reesink HW, Schinkel J, van der Valk M, van den Berk GEL, Brinkman K, Kwa D, van der Meche N, Toonen A, Vos D, van Broekhuizen M, Lauw FN, Mulder JW, Arends JE, van Kessel A, de Kroon I, Boonstra A, van der Ende ME, Hullegie S, Rijnders BJA, van de laar TJW, Gras L, Smit C, Lambers FAE, Prins M, Vanhommerig JW, van der Veldt W, Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control Study. OPEN FORUM INFECT DIS 2015;2 (3):ofv115 [PubMed]
Vanhommerig JW, van de Laar TJW, Koot M, van Rooijen MS, Schinkel J, Speksnijder AGCL, Prins M, de Vries HJ, Bruisten SM, Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV. J VIROL METHODS 2015;213:147-150 [PubMed]
Vriend HJ, Stolte IG, Heijne JCM, Heijman T, de Vries HJC, Geskus RB, van der Sande MAB, Prins M, Repeated STI and HIV testing among HIV-negative men who have sex with men attending a large STI clinic in Amsterdam: a longitudinal study. SEX TRANSM INFECT 2015;91 (4):294-299 [PubMed]
Willemse SB, Razavi-Shearer D, Zuure FR, Veldhuijzen IK, Croes EA, van der Meer AJ, van Santen DK, de Vree JM, de Knegt RJ, Zaaijer HL, Reesink HW, Prins M, Razavi H, The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms. NETH J MED 2015;73 (9):417-431 [PubMed]
[Contributors: Monge S, Jarrín I, Mocroft A, Sabin CA, Touloumi G, van sighem A, Abgrall S, Dray-Spira R, Spire B, Castagna A, Mussini C, Zangerle R, Hessamfar M, Anderson J, Hamouda O, Ehren K, Obel N, Kirk O, de Monteynard LA, Antinori A, Girardi E, Saracino A, Calmy A, de Wit S, Wittkop L, Bucher HC, Montoliu A, Raben D, Prins M, Meyer L, Chene G, Burns F, del Amo J]] , Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative cohort study. LANCET HIV 2015;2 (12):e540-e549 [PubMed]
de Vos AS. Heterogeneity in risk-behaviour matters; Modelling the spread of HIV and Hepatitis C Virus among injecting drug users. S.l.: s.n.; 2014. 135p. ISBN 978-90-8891-952-7 Proefschrift Utrecht University, UMCU, Public Health Service Amsterdam. (Promotor(s): Kretzschmar MEE, Prins M; copromotor(s): )
de Vos AS, Prins M, Coutinho RA, van der Helm JJ, Kretzschmar MEE, Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study. AIDS 2014;28 (6):911-918 [PubMed]
Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, D'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, de Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N [Contributors: Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, D'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, de Wit S, Burkholder G, Teira R, Justice A, R Sterling T, Crane HM, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Boulle A, Brodt HR, Casabona J, Cavassini M, Costagliola D, Dabis F, del Amo J, van Sighem A, Hans-Ulrich Haerry D, Hogg R, Mocroft A, Obel N, Kitahata M, Saag M, Sterling TR, Williams M, Ingle S, Touloumi G, Warszawski J, Krause MM, Ghosn J, Leport C, Wit F, Prins M, Gibb D, Thorne C, Pérez-Hoyos S, Hamouda O, Gussenheimer-Bartmeyer B, Noguera-Julian A, Antinori A, Brockmeyer N, Ramos J, Battegay M, Rauch A, Tookey P, Miró JM, de Wit S, Goetghebuer T, Torti C, Garrido M, Judd A, Conejo PR, Haerry D, Weller I, D'Arminio-Monforte A, Colin C, Schwimmer C, Termote M, Kjaer J, Campbell M, Raben D, Bohlius J, Bouteloup V, Bucher H, Cozzi-Lepri A, Dorrucci M, Egger M, Engsig F, Furrer H, Lambotte O, Lewden C, Lodi S, Lodwick R, Matheron S, Miro J, Monge S, Nakagawa F, Paredes R, Phillips A, Puoti M, Reekie J, Scherrer A, Smit C, Thiebaut R, Wittkop L]] , Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. CLIN INFECT DIS 2014;58 (9):1312-1321 [PubMed]
Grebely J, Dore GJ, Kim AY, Lloyd A, Shoukry NH, Prins M, Page K, Genetics of Spontaneous Clearance of Hepatitis C Virus Infection: A Complex Topic With Much to Learn. HEPATOLOGY 2014;60 (6):2127-2128 [PubMed]
Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M [Contributors: Page K, Bruneau J, Cox AL, Dore GJ, Grebely J, Hellard M, Lauer G, Kim AY, Lloyd AR, Maher L, McGovern BH, Prins M, Shoukry NH, Morris M, Hahn J, Rice TM, Rilla M, Alavi M, Bouchard R, Evans J, Grady B, Aneja J, Sacks-Davis R, Teutsch S, White B, Wells B, Zang G, Applegate T, Matthews G, Yeung B, Schinkel J, Prince LE, Roy E, Bates A, Enriquez J, Chow S, McCredie L, Aitken C, Doyle J, Spelman T]] , The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. HEPATOLOGY 2014;59 (1):109-120 [PubMed]
Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J [Contributors: Page K, Bruneau J, Cox AL, Dore GJ, Grebely J, Hellard M, Lauer G, Kim AY, Lloyd AR, Maher L, McGovern BH, Prins M, Shoukry NH, Morris M, Hahn J, Shiboski S, Rice TM, Alavi M, Bouchard R, Evans J, Grady B, Aneja J, Sacks-Davis R, Teutsch S, White B, Wells B, Zang G, Matthews G, Marks P, Yeung B, Prince LE, Roy E, Bates A, Enriquez J, Chow S, McCredie L, Aitken C, Doyle J, Spelman T]] , Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. J CLIN VIROL 2014;61 (3):430-434 [PubMed]
Kramer MA, van Veen MG, Op de Coul ELM, Coutinho RA, Prins M, Do sexual risk behaviour, risk perception and testing behaviour differ across generations of migrants?. EUR J PUBLIC HEALTH 2014;24 (1):134-138 [PubMed]
Lambers FAE, Prins M, Davidovich U, Stolte IG, High awareness of hepatitis C virus (HCV) but limited knowledge of HCV complications among HIV-positive and HIV-negative men who have sex with men. AIDS CARE 2014;26 (4):416-424 [PubMed]
Lazarus JV, Lundgren J, Casabona J, Wiessing L, Matheï C, Vickerman P, Prins M, Kretzschmar M, Kantzanou M, Giraudon I, Ferri M, Griffiths P, Harris M, Walker M, Chavdarova L, Schatz E, Schiffer K, Kools J, Farell J, Mendão L, Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. BMC INFECT DIS 2014;14 (Suppl. 6):S18 [PubMed]
Leopold SJ, Grady BPX, Lindenburg CEA, Prins M, Beuers U, Weegink CJ, Common Bile Duct Dilatation in Drug Users With Chronic Hepatitis C Is Associated With Current Methadone Use. J ADDICT MED 2014;8 (1):53-58 [PubMed]
Lodi S, Dray-Spira R, Touloumi G, Braun D, Teira R, D'Arminio Monforte A, Gallois A, Zangerle R, Spire B, Dabis F, Stähelin C, Termote M, Kirk O, Chêne G, Egger M, del Amo J [Contributors: Zangerle R, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause MM, Ghosn J, Leport C, Reiss P, Wit F, Prins M, Bucher H, Sabin C, Gibb D, Fätkenheuer G, del Amo J, Obel N, Thorne C, Mocroft A, Kirk O, Stephan C, Pérez-Hoyos S, Hamouda O, Bartmeyer B, Noguera-Julian A, Antinori A, D'Arminio Monforte A, Brockmeyer N, Ramos J, Conejo PR, Soriano T, Battegay M, Rauch A, Mussini C, Tookey P, Casabona J, Miró JM, Castagna A, Konopnick D, Goetghebuer T, Torti C, Teira R, Garrido M, Haerry D, de Wit S, Costagliola D, D'Arminio-Monforte A, Grarup J, Chêne G, Judd A, Barger D, Colin C, Schwimmer C, Termote M, Wittkop L, Campbell M, Friis-Møller N, Kjaer J, Raben D, Brandt RS, Bohlius J, Bouteloup V, Cozzi-Lepri A, Dorrucci M, Egger M, Engsig F, Furrer H, Lambotte O, Lodi S, Matheron S, Miro J, Monge S, Nakagawa F, Paredes R, Phillips A, Puoti M, Smit C, Sterne J, Thiebaut R, van der Valk M, Wyss N]] , Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord. AIDS 2014;28 (15):2297-2306 [PubMed]
Matser A, Vanhommerig J, Schim van der Loeff MF, Geskus RB, de Vries HJC, Prins JM, Prins M, Bruisten SM, Correction: HIV-Infected Men Who Have Sex with Men Who Identify Themselves as Belonging to Subcultures Are at Increased Risk for Hepatitis C Infection. PLOS ONE 2014;8 (4):e57740.correction [PubMed]
Mikolajczyk RT, Horn J, Prins M, Wiessing L, Kretzschmar M, Trajectories of injecting behavior in the Amsterdam Cohort Study among drug users. DRUG ALCOHOL DEPEN 2014;144:141-147 [PubMed]
Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, Lodi S, Ghosn J, Dorrucci M, Johnson A, Sannes M, Moreno S, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Fradette L, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Kelleher T, Cooper D, Gray P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Zangerle R, Gill J, Lutsar I, Dabis F, Costagliola D, Guiguet M, Vanhems P, Boufassa F, Bartmeyer B, Chrysos G, Daikos GL, Katsarou O, Dorrucci M, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran B, Rosinska M, Tor J, Garcia de Olalla PG, Cayla J, Monge S, del Romero J, Sönnerborg A, Rickenbach M, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Giaquinto C, Grarup J, Peters L, Reiss P, Thorne C, Aboulker JP, Albert J, Asandi S, Monforte AdA, del J, Gatell J, Ledergerber B, Lundgren J, Møller C, Rockstroh J, Sandhu M, Anne AV, Dedes N, Pizzuti D, Vitoria M, Faggion S, Frost R, Raben D, Schwimmer C, Scott M]] , Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype. JAIDS-J ACQ IMM DEF 2014;67 (1):15-21 [PubMed]
Olson AD, Meyer L, Prins M, Thiebaut R, Gurdasani D, Guiguet M, Chaix ML, Amornkul P, Babiker A, Sandhu MS, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Zangerle R, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Pantazis N, Katsarou O, Rezza G, Dorrucci M, Monforte AdA, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Bucher H, Burns F, Giaquinto C, Gibb D, Grarup J, Universitet K, Kirk O, Kjaer J, Panteleev A, Reiss P, Thorne C, Aboulker JP, Albert J, Asandi S, de Wit S, de Wolf F, Gatell J, Bíomèdica R, Karpov I, Ledergerber B, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Anne AV, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Fradette L, Frost R, Sabin M, Schwimmer C, Scott M]] , An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration. PLOS ONE 2014;9 (1):e86719 [PubMed]
Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P [Contributors: Wit FWNM, van der Valk M, Schouten J, Kooij KW, van Zoest RA, Elsenga BC, Prins M, Stolte IG, Martens M, Moll S, Berkel J, Möller L, Visser GR, Welling C, Zaheri S, Hillebregt MMJ, Gras LAJ, Ruijs YMC, Benschop DP, Reiss P, Kootstra NA, Harskamp-Holwerda AM, Maurer I, Ruiz MMM, Girigorie AF, van Leeuwen E, Janssen FR, Heidenrijk M, Schrijver JHN, Zikkenheiner W, Wezel M, Jansen-Kok CSM, Geerlings SE, Godfried MH, Goorhuis A, van der Meer JTM, Nellen FJB, van der Poll T, Prins JM, Wiersinga WJ, van Eden J, Henderiks A, van Hes AMH, Mutschelknauss M, Nobel HE, Pijnappel FJJ, Westerman AM, de Jong J, Postema PG, Bisschop PHLT, Serlie MJM, Lips P, Dekker E, de Rooij SEJA, Willemsen JMR, Vogt L, Portegies P, Schmand BA, Geurtsen GJ , Stege JAt, Twennaar MK, van Eck-Smit BLF, de Jong M, Richel DJ, Verbraak FD, Demirkaya N , Visser I, Ruhé HG, Nieuwkerk PT, van Steenwijk RP, Dijkers E, Majoie CBLM, Caan MWA, Su T, van Lunsen HW, Nievaard MAF, van den Born BJH, Stroes ESG, Mulder WMC]] , Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. CLIN INFECT DIS 2014;59 (12):1787-1797 [PubMed]
Simmons R, Semenenko I, Tolpina M, Tereschenko R, Kotlik L, Zasyptka L, Murphy G, McKinney E, Copas A, Malyuta R, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Pantazis N, Katsarou O, Rezza G, Dorrucci M, Monforte AdA, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Bakken Kran AM, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Giaquinto C, Gibb D, Grarup J, Kirk O, Universitet K, Ledergerber B, Panteleev A, Thorne C, Welch S, Aboulker JP, Albert J, Asandi S, de Wit S, de Wolf F, Gatell J, Karpov I, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Anne AV, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Fradette L, Frost R, Schwimmer C, Scott M]] , High percentage of recent HIV infection leading to onward transmission in Odessa, Ukraine associated with young adults. AIDS BEHAV 2014;18 (2):411-418 [PubMed]
Urbanus AT, van de Laar TJW, Geskus R, Vanhommerig JW, van Rooijen MS, Schinkel J, Heijman T, Coutinho RA, Prins M, Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS 2014;28 (5):781-790 [PubMed]
van den Boom W, Konings R, Davidovich U, Sandfort T, Prins M, Stolte IG, Is Serosorting Effective in Reducing the Risk of HIV Infection Among Men Who Have Sex With Men With Casual Sex Partners?. JAIDS-J ACQ IMM DEF 2014;65 (3):375-379 [PubMed]
van der Helm JJ. International epidemiological studies on HIV, HCV and STI. S.l.: s.n.; 2014. 221p. ISBN 9789064648076 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij Public Health Service of Amsterdam, -. (Promotor(s): de Vries HJC, Prins M; copromotor(s): Geskus RB)
van der Helm JJ, Geskus R, Lodi S, Meyer L, Schuitemaker H, Gunsenheimer-Bartmeyer B, Monforte AdA, Olson A, Touloumi G, Sabin C, Porter K, Prins M, Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study. LANCET HIV 2014;1 (1):E41-E48 [PubMed]
Vanhommerig JW, Stolte IG, Lambers FAE, Geskus RB, van de Laar TJW, Bruisten SM, Schinkel J, Prins M, Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam. JAIDS-J ACQ IMM DEF 2014;66 (5):e111-e115 [PubMed]
Vanhommerig JW, Thomas XV, van der Meer JTM, Geskus RB, Bruisten SM, Molenkamp R, Prins M, Schinkel J [Contributors: Arends J, van Baarle D, van den Berk G, Brinkman K, Coutinho R, van den Ende M, Grady B, Gras L, Ho C, Kwa D, van de Laar T, Lambers F, Mulder J, Reesink H, Smit C, van der Valk M, van der Veldt W, Karlas J, Bakker M, Visser G, Buswell C]] , Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men. CLIN INFECT DIS 2014;59 (12):1678-1685 [PubMed]
van Santen DK, van der Helm JJ, Grady BPX, de Vos AS, Kretzschmar MEE, Stolte IG, Prins M, Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status. AIDS 2014;28 (17):2589-2599 [PubMed]
Vriend HJ. Interventions for STI control: vaccination and testing. S.l.: s.n.; 2014. 236p. ISBN 9789461087621 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Prins M; copromotor(s): van der Sande MAB)
White B, Madden A, Prins M, Hellard M, Wand H, Dore GJ, Page K, Maher L, Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study. VACCINE 2014;32 (42):5460-5467 [PubMed]
Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ, Hatzakis A, Prins M, Vickerman P, Lazarus JV, Hope VD, Matheï C [Contributors: Busch M, Bollaerts K, Bogdanova V, Nesheva E, Fotsiou N, Kostrikis L, Mravčík V, Řehák V, Částková J, Hobstová J, Nechanská B, Fouchard J, Abel-Ollo K, Tefanova V, Tallo T, Brummer-Korvenkontio H, Brisacier AC, Michot I, Jauffret-Roustide M, Zimmermann R, Fotiou A, Gazdag G, Tarján A, Galvin B, Garavan C, Thornton L, Cruciani M, Basso M, Karnīte A, Caplinskiene I, Lopes S, Origer A, Melillo J, Camilleri M, Demanuele CO, Croes E, Op de Coul E, Rosińska M, Struzik M, Martins M, Duran D, Vilar G, Resende ME, Martins HC, Abagiu AO, Ruta S, Arama V, Kopilovic B, Kustec T, Klavs I, Aleixandre NL, Folch C, Bravo MJ, Gómez RS, Berglund T, Strandberg J, Hope V, Hotho D, van Houdt S, Low A, Mcdonald B, Platt L, Kalamara E, Giraudon I, Groshkova T, Palladino C, Hutchinson S, Ncube F, Eramova I, Goldberg D, Vicente J, Griffiths P]] , Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLOS ONE 2014;9 (7):e103345 [PubMed]
Zuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CHSB, Davidovich U, Prins M, Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC PUBLIC HEALTH 2014;14 (1):66 [PubMed]
[Contributors: Nakagawa F, Lodwick R, Smith C, Costagliola D, van Sighem A, Ledergerber B, D'Arminio Monforte A, Dorrucci M, Torti C, Suarez-Lozano I, Obel N, Brockmeyer N, Thiebaut R, Lundgren J, Castagna A, Alejos B, de Wit S, Zangerle R, Pantazis N, Ehren K, Casabona J, Grarup J, Chêne G, Phillips A, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause MM, Ghosn J, Leport C, Reiss P, Wit F, Prins M, Bucher HC, Sabin C, Gibb D, Fätkenheuer G, del Amo J, Thorne C, Mocroft A, Kirk O, Stephan C, Pérez-Hoyos S, Hamouda O, Gussenheimer-Bartmeyer B, Noguera-Julian A, Antinori A, Ramos J, Battegay M, Rauch A, Mussini C, Tookey P, Miró JM, de Wit S, Goetghebuer T, Teira R, Garrido M, Judd A, Haerry D, Weller I, D'Arminio-Monforte A, Colin C, Schwimmer C, Termote M, Barger D, Kjaer J, Campbell M, Raben D, Bohlius J, Bouteloup V, Bucher H, Cozzi-Lepri A, Egger M, Engsig F, Furrer H, Lambotte O, Lewden C, Lodi S, Matheron S, Miro J, Monge S, Paredes R, Puoti M, Reekie J, Scherrer A, Smit C, Sterne J, Wittkop L]] , Factors associated with short-term changes in HIV viral load and CD4 R cell count in antiretroviral-naive individuals. AIDS 2014;28 (9):1351-1356 [PubMed]
Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, de Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Perez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chêne G, Grarup J, Phillips A, Lodwick R, Günthard HF, Michalik C, Chrysos G [Contributors: Audelin A, Castagna A, Costagliola D, Cozzi-Lepri A, de Luca A, de Wit S, de Wolf F, Dorrucci M, Duval X, Fätkenheuer G, García F, Ghosn J, Günthard H, Jansen K, Judd A, Ledergerber B, Lo Caputo S, Lodwick R, Masquelier B, Meyer L, Mocroft A, Mussini C, Noguera-Julian A, Obel N, Paraskevis D, Paredes R, Pérez-Hoyos S, Phillips A, Pillay D, Podzamczer D, Ramos JT, Stephan C, Tookey PA, Torti C, Touloumi G, van Sighem A, Warsawski J, Zangerle R, Warszawski J, Dabis F, Krause MM, Leport C, Reiss P, Prins M, Bucher H, Sabin C, Gibb D, del Amo J, Thorne C, Kirk O, Antinori A, D'Arminio Monforte A, Brockmeyer N, Ramos J, Battegay M, Rauch A, Tookey P, Casabona J, Miró JM, Goetghebuer T, Teira R, Garrido M, Haerry D, Weller I, D'Arminio-Monforte A, Grarup J, Chene G, Bohlius J, Bouteloup V, Egger M, Engsig F, Furrer H, Lambotte O, Lewden C, Matheron S, Miro J, Puoti M, Reekie J, Scherrer A, Smit C, Sterne J, Thiebaut R, von Wyl V, Wittkop L]] , Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes. J INFECT DIS 2013;207 (5):759-767 [PubMed]
de Vos AS, van der Helm JJ, Matser A, Prins M, Kretzschmar MEE, Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?. ADDICTION 2013;108 (6):1070-1081 [PubMed]
Grady BPX, Prins M, van der Loeff MS, The sexual transmission rate of HCV among heterosexual couples. HEPATOLOGY 2013;58 (5):1865-1866 [PubMed]
Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K, Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. INT J EPIDEMIOL 2013;42 (6):1649-1659 [PubMed]
Grijsen ML, Vrouenraets SME, Wit FWNM, Stolte IG, Prins M, Lips P, Reiss P, Prins JM, Low bone mineral density, regardless of HIV status, in men who have sex with men. J INFECT DIS 2013;207 (3):386-391 [PubMed]
Huang X, Lodi S, Fox Z, Li W, Phillips A, Porter K, Lutsar I, Kelleher A, Li N, Xu X, Wu H, Johnson AM [Contributors: Huang X, Liu Z, Wei F, Ji Y, Zhang T, Fu Y, Xia W, Yan H, Zhang X, Li W, Jiang Y, Pan PL, del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Zangerle R, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Antoniadou A, Chrysos G, Daikos GL, Touloumi G, Pantazis N, Katsarou O, Rezza G, Dorrucci M, Monforte AdA, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Bucher H, Burns F, Giaquinto C, Gibb D, Grarup J, Kirk O, Kjaer J, Panteleev A, Reiss P, Thorne C, Aboulker JP, Albert J, Asandi S, de Wit S, de Wolf F, Gatell J, Karpov I, Ledergerber B, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Anne AV, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Fradette L, Frost R, Sabin M, Schwimmer C, Scott M]] , Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts. JAIDS-J ACQ IMM DEF 2013;62 (4):441-446 [PubMed]
Jazaeri Farsani SM, Jebbink MF, Deijs M, Canuti M, van Dort KA, Bakker M, Grady BPX, Prins M, van Hemert FJ, Kootstra NA, van der Hoek L, Identification of a new genotype of Torque Teno Mini virus. VIROL J 2013;10 (1):323 [PubMed]
Lodi S, del Amo J, D'Arminio Monforte A, Abgrall S, Sabin C, Morrison C, Furrer H, Muga R, Porter K, Girardi E [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Boufassa F, Kücherer C, Bartmeyer B, Touloumi G, Pantazis N, Katsarou O, Rezza G, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Giaquinto C, Grarup J, Ledergerber B, Panteleev A, Thorne C, Welch S, Aboulker JP, Albert J, Asandi S, de Wolf F, Gatell J, Koch R, Karpov I, Lundgren J, Møller C, Rockstroh J, Anne AV, Dedes N, Pizzuti D, Vitoria M, Faggion S, Fradette L, Frost R, Schwimmer C, Scott M, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Pérez-Hoyos S, Kirk O, de Wit S, Rakhmanova A, Dorrucci M, Karita E]] , Risk of tuberculosis following HIV seroconversion in high-income countries. THORAX 2013;68 (3):207-213 [PubMed]
Lodi S, Fisher M, Phillips A, de Luca A, Ghosn J, Malyuta R, Zangerle R, Moreno S, Vanhems P, Boufassa F, Guiguet M, Porter K [Contributors: Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Zangerle R, Gill J, Lutsar I, Chêne G, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Meyer L, Boufassa F, Hamouda O, Kücherer C, Bartmeyer B, Antoniadou A, Chrysos G, Daikos GL, Touloumi G, Pantazis N, Katsarou O, Rezza G, Dorrucci M, D'Arminio Monforte A, de Luca A, Prins M, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Bakken Kran AM, Rosinska M, Muga R, Tor J, Garcia de Olalla P, Cayla J, del Amo J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Bucher HC, Rickenbach M, Francioli P, Malyuta R, Murphy G, Sabin C, Porter K, Johnson A, Phillips A, Babiker A, Pillay D, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E]] , Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection. PLOS ONE 2013;8 (11):e78642 [PubMed]
Madec Y, Boufassa F, Porter K, Prins M, Sabin C, D'Arminio Monforte A, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Pantazis N, Katsarou O, Rezza G, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Bakken Kran AM, Rosinska M, Tor J, Garcia de Olalla P, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Giaquinto C, Gibb D, Grarup J, Kirk O, Ledergerber B, Panteleev A, Thorne C, Welch S, Aboulker JP, Albert J, Asandi S, de Wit S, de Wolf F, Gatell J, Karpov I, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Volny Anne A, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Fradette L, Frost R, Schwimmer C, Scott M]] , Natural history of HIV-control since seroconversion. AIDS 2013;27 (15):2451-2460 [PubMed]
Matser A, Vanhommerig J, Schim van der Loeff MF, Geskus RB, de Vries HJC, Prins JM, Prins M, Bruisten SM, HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infection. PLOS ONE 2013;8 (3):e57740 [PubMed]
Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD [Contributors: Mocroft A, Furrer H, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, D'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh J, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD, Lundgren J, Miiro J, Palacin PS, Torti C, Warszawski J, Rockstroh J, Ramos J, Miró JM, Munoz P, Judd A, Haerry D, Weller I, Casabona J, Costagliola D, D'Arminio-Monforte A, Battegay M, Prins M, de Wolf F, Colin C, Schwimmer C, Touzeau G, Campbell M, Bohlius J, Bouteloup V, Bucher H, Cozzi-Lepri A, Dabis F, Dorrucci M, Egger M, Engsig F, Lambotte O, Lewden C, Lodwick R, Matheron S, Miro J, Paredes R, Phillips A, Puoti M, Reekie J, Sabin C, Scherrer A, Smit C, Sterne J, Thiebaut R, Thorne C, von Wyl V, Wittkop L, Young J]] , The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. CLIN INFECT DIS 2013;57 (7):1038-1047 [PubMed]
Mocroft A, Lundgren JD, Sabin ML, Monforte AdA, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, de Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O [Contributors: Mocroft A, Lundgren J, Sabin M, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, de Wit S, Fätkenheuer G, Furrer H, Johnson A, Lazanas M, Leport C, Moreno S, Obel N, Post F, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Warszawski J, Zangerle R, Kjaer J, Chene G, Grarup J, Kirk O, Johnson HFA, Torti C, Touloumi G, Meyer L, Dabis F, Krause MM, Ghosn J, de Wolf F, Prins M, Bucher H, Gibb D, Hamouda O, Bartmeyer B, del Amo J, Thorne C, Stephan C, Pérez-Hoyos S, Noguera-Julian A, Antinori A, Monforte AdA, Ramos J, Battegay M, Rauch A, Mussini C, Tookey P, Miro JM, de Wit S, Goetghebuer T, Teira R, Garrido M, Judd A, Haerry D, Weller I, Fabre-Colin C, Schwimmer C, Termote M, Touzeau G, Campbell M, Friis-Møller N, Bohlius J, Bouteloup V, Cozzi-Lepri A, Dorrucci M, Egger M, Engsig F, Lambotte O, Lewden C, Lodwick R, Matheron S, Miro J, Paredes R, Phillips A, Puoti M, Scherrer A, Smit C, Sterne J, Thiebaut R, von Wyl V, Wittkop L]] , Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLOS MED 2013;10 (9):e1001510 [PubMed]
Page K, Morris MD, Hahn JA, Maher L, Prins M, Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. CLIN INFECT DIS 2013;57 (Suppl. 2):S32-S38 [PubMed]
Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, de Gottardi A, Swan T, Arain A, Kautz A, Stöver H, Wedemeyer H, Schaefer M, Taylor L, Backmund M, Dalgard O, Prins M, Dore GJ, Recommendations for the management of hepatitis C virus infection among people who inject drugs. CLIN INFECT DIS 2013;57 (Suppl. 2):S129-S137 [PubMed]
Rosińska M, Marzec-Bogustawska A, Janiec J, Smoleń-Dzirba J, Wąsik T, Gniewosz J, Zalewska M, Murphy G, McKinney E, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Gill J, Ülikool T, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Gargalianos-Kakolyris P, Lazanas M, Pantazis N, Katsarou O, Rezza G, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Giaquinto C, Malyuta R, Di G, Grarup J, Universitet K, Kirk O, Ledergerber B, Panteleev A, Thorne C, Welch S, Aboulker JP, Albert J, Asandi S, de Wit S, de Wolf F, Gatell J, Karpov I, Lundgren J, Møller C, Rockstroh J, Anne AV, Dedes N, Fenton K, Pizzuti D, Vitoria M, Ellefson M, Faggion S, Frost R, Schwimmer C, Scott M]] , High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland. AIDS RES HUM RETROV 2013;29 (5):805-813 [PubMed]
Stronks K, Snijder MB, Peters RJG, Prins M, Schene AH, Zwinderman AH, Unravelling the impact of ethnicity on health in Europe: the HELIUS study. BMC PUBLIC HEALTH 2013;13 (1):402 [PubMed]
Urbanus AT. Hepatitis C virus infection: spread and impact in the Netherlands. s.l.: s.n.; 2013. 200p. ISBN 9789064646386 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Coutinho RA, Prins M; copromotor(s): )
Urbanus AT, van Keep M, Matser AA, Rozenbaum MH, Weegink CJ, van den Hoek A, Prins M, Postma MJ, Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?. PLOS ONE 2013;8 (8):e70319 [PubMed]
van den Berg CHSB, Nanlohy NM, van de Laar TJW, Prins M, van Baarle D, Ongoing risk behavior and the presence of HCV-RNA affect the hepatitis C virus (HCV)-Specific CD4(+) T cell response. VIRAL IMMUNOL 2013;26 (3):216-219 [PubMed]
van den Boom W, Stolte IG, Witlox R, Sandfort T, Prins M, Davidovich U, Undetectable viral load and the decision to engage in unprotected anal intercourse among HIV-positive MSM. AIDS BEHAV 2013;17 (6):2136-2142 [PubMed]
van der Helm J, Geskus R, Sabin C, Meyer L, del Amo J, Chene G, Dorrucci M, Muga R, Porter K, Prins M [Contributors: del Amo J, Meyer L, Bucher HC, Chene G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Ghosn J, Boufassa F, Kuecherer C, Bartmeyer B, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Pantazis N, Katsarou O, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Chaix ML, Rezza G]] , Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. GASTROENTEROLOGY 2013;144 (4):751-760.e2 [PubMed]
van der Knaap N, Grady BPX, Schim van der Loeff MF, Heijmans T, Speksnijder A, Geskus R, Prins M, Druggebruikers in Amsteredam: lopen ze nog risico op hiv?. INFECTIEZIEKTEN-BULL 2013;24 (10):321-327
van der Knaap N, Grady BPX, Schim van der Loeff MF, Heijman T, Speksnijder A, Geskus R, Prins M, Drug users in Amsterdam: are they still at risk for HIV?. PLOS ONE 2013;8 (3):e59125 [PubMed]
Vriend HJ, Lugnér AK, Xiridou M, Schim van der Loeff MF, Prins M, de Vries HJC, Geerlings SE, Prins JM, Rijnders BJA, van Veen MG, Fennema JSA, Postma MJ, van der Sande MAB, Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective. AIDS 2013;27 (14):2281-2290 [PubMed]
Vriend HJ, van Veen MG, Prins M, Urbanus AT, Boot HJ, Op de Coul ELM, Hepatitis C virus prevalence in The Netherlands: migrants account for most infections. EPIDEMIOL INFECT 2013;141 (6):1310-1317 [PubMed]
White B, Madden A, Hellard M, Kerr T, Prins M, Page K, Dore GJ, Maher L, Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs. DRUG ALCOHOL REV 2013;32 (4):419-425 [PubMed]
Xiridou M, Vriend HJ, Lugner AK, Wallinga J, Fennema JS, Prins JM, Geerlings SE, Rijnders BJA, Prins M, de Vries HJC, Postma MJ, van Veen MG, Schim van der Loeff MF, van der Sande MAB, Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men. BMC INFECT DIS 2013;13 (1):436 [PubMed]
Zuure FR. Screening for hepatitis C virus infection of individuals at risk hidden among the general population. s.l.: s.n.; 2013. -p. Proefschrift Univeriteit van Maastricht, Geneeskunde. (Promotor(s): Kok G, Prins M; copromotor(s): Davidovich E)
Zuure FR, Bouman J, Martens M, Vanhommerig JW, Urbanus AT, Davidovich U, van Houdt R, Speksnijder AGCL, Weegink CJ, van den Hoek A, Prins M, Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands. LIVER INT 2013;33 (5):727-738 [PubMed]
Castro-Sánchez A, Shkedy Z, Hens N, Aerts M, Geskus R, Prins M, Wiessing L, Kretzschmar M, Estimating the force of infection for HCV in injecting drug users using interval-censored data. EPIDEMIOL INFECT 2012;140 (6):1064-1074 [PubMed]
de Vos AS, van der Helm JJ, Prins M, Kretzschmar ME, Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. EPIDEMICS-NETH 2012;4 (2):57-67 [PubMed]
Fennema H, Prins M, Das K, Verhoeff A, Woudenberg F, editors, Beloftevol onderzoek 2002-2012 : Tien jaar research & development GGD Amsterdam. Amsterdam: GGD Amsterdam; 2012. 56p.
Grady BPX, Vanhommerig JW, Schinkel J, Weegink CJ, Bruisten SM, Lindenburg CEA, Prins M, Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam. EUR J GASTROEN HEPAT 2012;24 (11):1302-1307 [PubMed]
Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ, Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. LANCET INFECT DIS 2012;12 (5):408-414 [PubMed]
Heijman T, Geskus RB, Davidovich U, Coutinho RA, Prins M, Stolte IG, Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era. AIDS 2012;26 (4):489-495 [PubMed]
Heiligenberg M, Loeff MFSvd, de Vries HJC, Speksnijder AGCL, Geerlings SE, Coutinho R, Prins M, Prins JM, Low prevalence of asymptomatic sexually transmitted infections in HIV-infected heterosexuals visiting an HIV clinic in the Netherlands. AIDS 2012;26 (5):646-649 [PubMed]
Heiligenberg M, Rijnders B, Schim van der Loeff MF, de Vries HJC, van der Meijden WI, Geerlings SE, Fennema HSA, Prins M, Prins JM, High prevalence of sexually transmitted infections in HIV-infected men during routine outpatient visits in the Netherlands. SEX TRANSM DIS 2012;39 (1):8-15 [PubMed]
Heiligenberg M, Wermeling PR, van Rooijen MS, Urbanus AT, Speksnijder AGCL, Heijman T, Prins M, Coutinho RA, Schim van der Loeff MF, Recreational Drug Use During Sex and Sexually Transmitted Infections Among Clients of a City Sexually Transmitted Infections Clinic in Amsterdam, The Netherlands. SEX TRANSM DIS 2012;39 (7):518-527 [PubMed]
Jarrin I, Pantazis N, Gill MJ, Geskus R, Perez-Hoyos S, Meyer L, Prins M, Touloumi G, Johnson A, Hamouda O, de Olalla PG, Porter K, del Amo J [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher AD, Cooper DA, Grey P, Finlayson R, Bloch M, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Gill J, Tartu Ü, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Ku C, Bartmeyer B, Pantazis N, Katsarou O, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Rezza G, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Pérez S, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul P, Giaquinto C, Gibb D, Grarup J, Kirk O, Ledergerber B, Panteleev A, Thorne C, Welch S, Aboulker JP, Albert J, Asandi S, DeWit S, de Wolf F, Gatell J, Koch R, Karpov I, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Volny Anne A, Dedes N, Fenton K, Pizzuti D, Vitoria M, Ellefson M, Faggion S, Frost R, Reynolds M, Schwimmer C, Scott M]] , Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. CLIN INFECT DIS 2012;54 (1):111-118 [PubMed]
Lewden C, Bouteloup V, de Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, D'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G [Contributors: Lewden C, Bouteloup V, Touloumi G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Raffi F, van Sighem A, Perez-Hoyos S, Sabin C, Wasmuth JC, Sobrino P, Perez-Cachafeiro S, Obel N, Mocroft A, Kirk O, Staszewski S, Stephan C, Castagna A, D'Arminio Monforte A, Ridolfo A, Torti C, Mussini C, Isern V, Calmy A, de Wit S, Teira R, Egger M, Chêne G, Zangerle R, Warszawski J, Meyer L, Mary- Krause M, de Wolf F, Reiss P, Prins M, Bucher H, Gibb D, Fätkenheuer G, del Amo J, Thorne C, Pérez-Hoyos S, Noguera-Julian A, Antinori A, Brockmeyer N, Ramos J, Battegay M, Rauch A, Tookey P, Casabona J, Miro JM, de Wit S, Goetghebuer T, Teira R, Garrido M, Haerry D, Weller I, Costagliola D, D'Arminio-Monforte A, Grarup J, Chene G, Colin C, Schwimmer C, Touzeau G, Kjaer J, Paulsen M, Bohlius J, Cozzi-Lepri A, Dorrucci M, Engsig F, Furrer H, Lambotte O, Lodwick R, Matheron S, Miro J, Paredes R, Phillips A, Puoti M, Reekie J, Scherrer A, Smit C, Sterne J, Thiebaut R, von Wyl V, Wittkop L, Young J]] , All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. INT J EPIDEMIOL 2012;41 (2):433-445 [PubMed]
Markov PV, van de Laar TJ, Thomas XV, Aronson SJ, Weegink CJ, van den Berk GE, Prins M, Pybus OG, Schinkel J, Colonial History and Contemporary Transmission Shape the Genetic Diversity of Hepatitis C Virus Genotype 2 in Amsterdam. J VIROL 2012;86 (14):7677-7687 [PubMed]
Matser A, Urbanus A, Geskus R, Kretzschmar M, Xiridou M, Buster M, Coutinho R, Prins M, The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam. ADDICTION 2012;107 (3):614-623 [PubMed]
Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Lodi S, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher AD, Cooper DA, Grey P, Finlayson R, Bloch M, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Gill J, Jørgensen LB, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Pantazis N, Katsarou O, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Rezza G, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, Garcia de Olalla P, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Brettle R, Murphy G, Johnson A, Phillips A, Delpech V, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul P, Giaquinto C, Gibb D, Grarup J, Kirk O, Ledergerber B, Panteleev A, Thorne C, Welch S, Aboulker JP, Albert J, Asandi S, de Wit S, de Wolf F, Gatell J, Karpov I, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Volny Anne A, Dedes N, Fenton K, Pizzuti D, Vitoria M, Faggion S, Frost R, Fradette L, Schwimmer C, Scott M, Minga A, Lewden C, Abo Y, Dohoun L, Drowa EAY, Bades IB, Kouamé T, N'Dri MJ, Ouattara M, Sidibé A, Afi R, Emieme A, Inwoley A, Toni TdA, Coulibaly A, Bomisso G, Konaté M, Anglaret X, Bazin B, Danel C, Deveau C, Goujard C, Quinty L, Salamon R, Thiébaut R, Rouzioux C, Sinet M, Karita E, Allen S, Anzala O, Bekker LG, Inambao M, Kamali A, Kilembe W, Lakhi S, Latka MH, Sanders E, Mutua G, Mwangome M, Ruzagira E, Twesigye R, Amornkul PN, Cormier E, Fast P, Gilmour J, Krebs M, Price M, Stevens G, Thomson H, Yates S, Kaleebu P, Hunter E, Byamugisha J, Magwali T]] , Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa. PLOS ONE 2012;7 (3):e32369 [PubMed]
van Houdt R, Bruisten SM, Speksnijder AGCL, Prins M, Unexpectedly high proportion of drug users and men having sex with men who develop chronic hepatitis B infection. J HEPATOL 2012;57 (3):529-533 [PubMed]
van Sighem A, Jansen I, Bezemer D, de Wolf F, Prins M, Stolte I, Fraser C, Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data. AIDS 2012;26 (14):1840-1843 [PubMed]
Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, Castagna A, de Wit S, Muñoz J, Kjaer J, Grarup J, Chêne G, Bucher H [Contributors: Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, Castagna A, de Wit S, Muñoz J, Kjær J, Colin C, Grarup J, Chêne G, Bucher H, Miro J, Zangerle R, Antoniadou A, Ghosn J, Morlat P, Le Moing V, Fisher M, Mocroft A, Stephan C, Girardi E, Torti C, Mussini C, Galli L, Ledergerber B, Teira R, Touloumi G, Warszawski J, Dabis F, Krause MM, Leport C, de Wolf F, Prins M, Bücher H, Sabin C, Gibb D, Fätkenheuer G, del Amo J, Thorne C, Pérez-Hoyos S, Noguera-Julian A, Antinori A, D'Arminio Monforte A, Brockmeyer N, Ramos J, Battegay M, Rauch A, Tookey P, Casabona J, de Wit S, Goetghebuer T, Teira R, Garrido M, Haerry D, Weller I, Costagliola D, D'Arminio-Monforte A, Schwimmer C, Touzeau G, Paulsen M, Bohlius J, Bouteloup V, Cozzi-Lepri A, Dorrucci M, Egger M, Engsig F, Lambotte O, Lewden C, Lodwick R, Matheron S, Paredes R, Phillips A, Puoti M, Reekie J, Scherrer A, Smit C, Sterne J, Thiebaut R, von Wyl V, Wittkop L]] , CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLOS MED 2012;9 (3):e1001194 [PubMed]
Zugna D, Geskus RB, de Stavola B, Rosinska M, Bartmeyer B, Boufassa F, Chaix ML, Babiker A, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Pantazis N, Katsarou O, Rezza G, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, Garcia de Olalla P, Cayla J, Moreno S, Monge S, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Giaquinto C, Gibb D, Grarup J, Kirk O, Ledergerber B, Panteleev A, Thorne C, Welch S, Aboulker JP, Albert J, Asandi S, de Wit S, de Wolf F, Gatell J, Karpov I, Lundgren J, Møller C, Rakhmanova A, Rockstroh J, Anne AV, Dedes N, Fenton K, Pizzuti D, Vitoria M, Ellefson M, Faggion S, Fradette L, Frost R, Schwimmer C, Scott M]] , Time to virological failure, treatment change and interruption for individuals treated within 12 months of HIV seroconversion and in chronic infection. ANTIVIR THER 2012;17 (6):1039-1048 [PubMed]
[Contributors: Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, de Wit S, Stephan C, Obel N, Fätkenheuer G, Castagna A, Sambatakou H, Mussini C, Ghosn J, Zangerle R, Duval X, Meyer L, Perez-Hoyos S, Colin CF, Kjaer J, Chene G, Grarup J, Phillips A, de Luca A, de Wolf F, Günthard H, Jørgensen L, Judd A, Lo Caputo S, Noguera-Julian A, Paraskevis D, Paredes R, Pérez-Hoyos S, Pillay D, Ramos JT, Tookey PA, Touloumi G, Warsawski J, Warszawski J, Dabis F, Krause MM, Leport C, Reiss P, Prins M, Bücher H, Sabin C, Gibb D, del Amo J, Thorne C, Kirk O, Antinori A, D'Arminio Monforte A, Brockmeyer N, Ramos J, Battegay M, Rauch A, Tookey P, Casabona J, Miró JM, Goetghebuer T, Teira R, Garrido M, Haerry D, Weller I, D'Arminio-Monforte A, Colin C, Schwimmer C, Touzeau G, Paulsen M, Bohlius J, Bouteloup V, Bucher H, Egger M, Engsig F, Furrer H, Lambotte O, Lewden C, Matheron S, Miro J, Puoti M, Reekie J, Scherrer A, Smit C, Sterne J, Thiebaut R, von Wyl V, Wittkop L, Youn J]] , Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe. JAIDS-J ACQ IMM DEF 2012;59 (3):294-299 [PubMed]
[Contributors: Lodwick R, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, de Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Phillips A, Costagliola D, Cozzi-Lepri A, de Wolf F, Günthard H, Jørgensen L, Judd A, Caputo SL, Noguera-Julian A, Paraskevis D, Paredes R, Pillay D, Ramos JT, Stephan C, Tookey A, Warszawski J, Dabis F, Krause MM, Leport C, Reiss P, Prins M, Bücher H, Sabin C, Gibb D, del Amo J, Thorne C, Antinori A, D'Arminio Monforte A, Brockmeyer N, Battegay M, Rauch A, Tookey P, Casabona J, Miró M, Goetghebuer T, Teira R, Garrido M]] , Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. LANCET INFECT DIS 2012;12 (2):119-127 [PubMed]
Bohlius J, Schmidlin K, Boué F, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Paparizos V, Miro JM, Obel N, Prins M, Chêne G, Egger M, HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4(+) T-cell lymphocytes. BLOOD 2011;117 (23):6100-6108 [PubMed]
Grady B, van den Berg C, van der Helm J, Schinkel J, Coutinho R, Krol A, Prins M, No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion. CLIN GASTROENTEROL H 2011;9 (9):786-792.e1 [PubMed]
Jaffe HW, de Stavola BL, Carpenter LM, Porter K, Cox DR [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Lodi S, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher AD, Cooper DA, Grey P, Finlayson R, Bloch M, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Gill J, Jørgensen LB, Tartu U, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Pantazis N, Katsarou O, Rezza G, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, Garcia de Olalla P, Cayla J, Moreno S, Monge S, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Brettle R, Johnson A, Phillips A, Delpech V, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul P]] , Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS 2011;25 (11):1395-1403 [PubMed]
Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, Prins M, Stolte IG, Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 2011;25 (4):493-501 [PubMed]
Kramer MA. Travel and miggration. HIV and STIs among ethnic groups in the Netherlands. s.l.: s.n.; 2011. 154p. ISBN 9789461081308 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Coutinho RA; copromotor(s): Op de Coul ELM, Prins M)
Kramer MA, Cornelissen M, Paraskevis D, Prins M, Coutinho RA, van Sighem AI, Sabajo L, Duits AJ, Winkel CN, Prins JM, van der Ende ME, Kauffmann RH, Op de Coul EL, HIV Transmission Patterns Among The Netherlands, Suriname, and The Netherlands Antilles: A Molecular Epidemiological Study. AIDS RES HUM RETROV 2011;27 (2):123-130 [PubMed]
Lambers FAE, Brinkman K, Schinkel J, Spijkerman IJB, Molenkamp R, Coutinho RA, Prins M, van der Meer JTM [Contributors: Reesink H, van Baarle D, Smit C]] , Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration. AIDS 2011;25 (10):1333-1336 [PubMed]
Lambers FAE, Prins M, Thomas X, Molenkamp R, Kwa D, Brinkman K, van der Meer JTM, Schinkel J [Contributors: Countinho R, Reesink H, van Baarle D, Smit C, Gras L, van der Veldt W]] , Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 2011;25 (17):F21-F27 [PubMed]
Lambers FAE, Stolte IG, van den Berg CHSB, Coutinho RA, Prins M, Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam. INT J DRUG POLICY 2011;22 (3):210-218 [PubMed]
Lindenburg CEA, Lambers FAE, Urbanus AT, Schinkel J, Jansen PLM, Krol A, Casteelen G, van Santen G, van den Berg CHSB, Coutinho RA, Prins M, Weegink CJ, Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project. EUR J GASTROEN HEPAT 2011;23 (1):23-31 [PubMed]
Rachinger A, Manyenga P, Burger JA, Derks van de Ven TLP, Stolte IG, Prins M, van 't Wout AB, Schuitemaker H, Low Incidence of HIV-1 Superinfection Even After Episodes of Unsafe Sexual Behavior of Homosexual Men in the Amsterdam Cohort Studies on HIV Infection and AIDS. J INFECT DIS 2011;203 (11):1621-1628 [PubMed]
Urbanus AT, van de Laar TJW, van den Hoek A, Zuure FR, Speksnijder AGCL, Baaten GGG, Heijman T, Vriend HJ, Op de Coul ELM, Coutinho RA, Prins M, Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?. J HEPATOL 2011;55 (6):1207-1214 [PubMed]
Urbanus AT, van den Hoek A, Boonstra A, van Houdt R, de Bruijn LJ, Heijman T, Coutinho RA, Prins M, People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands. PLOS ONE 2011;6 (9):e24736 [PubMed]
van den Berg CHBS, Grady BPX, Schinkel J, van de Laar T, Molenkamp R, van Houdt R, Coutinho RA, van Baarle D, Prins M, Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLOS ONE 2011;6 (11):e27555 [PubMed]
van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB [Contributors: Meyer L, Pillay D, Rosinska M, Sabin C, Touloumi G, Lodi S, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Bruun Jørgensen L, Nielsen C, Pedersen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Kücherer C, Bartmeyer B, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidou A, Rezza G, Balotta C, D'Arminio Monforte A, Cozzi-Lepri A, Schuitemaker H, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Brettle R, Murphy G, Johnson A, Phillips A, Delpech V, Jaffe H, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul P]] , The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011;25 (8):1083-1091 [PubMed]
van Veen MG, Schaalma H, van Leeuwen AP, Prins M, de Zwart O, van de Laar MJW, Hospers HJ, Concurrent partnerships and sexual risk taking among African and Caribbean migrant populations in the Netherlands. INT J STD AIDS 2011;22 (5):245-250 [PubMed]
Xiridou M, van Veen M, Prins M, Coutinho R, How patterns of migration can influence the heterosexual transmission of HIV in The Netherlands. SEX TRANSM INFECT 2011;87 (4):289-291 [PubMed]
Zuure FR, Davidovich U, Coutinho RA, Kok G, Hoebe CJPA, van den Hoek A, Jansen PLM, van Leeuwen-Gilbert P, Verheuvel NC, Weegink CJ, Prins M, Using Mass Media and the Internet As Tools to Diagnose Hepatitis C Infections in the General Population. AM J PREV MED 2011;40 (3):345-352 [PubMed]
Zuure FR, Heijman T, Urbanus AT, Prins M, Kok G, Davidovich U, Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study. BMC PUBLIC HEALTH 2011;11 (1):293 [PubMed]
[Contributors: Albert M, Benito J, Bhagani S, Boesecke C, Deterding K, Dominguez S, Fisher M, Fontanet A, Garcia D, Gilson R, Guiguet M, Hoepelman AIM, Horban A, Katlama C, Mallolas J, Page E, Peters L, Pozniak A, Prins M, Puoti M, Rauch A, Rodger A, Rockstroh JK, Soriano V, Stephan C, Thibault V, Tural C, Valantin MA, van de Laar T, van der Meer J, Vella S, Vogel M, de Wit S, Autran B, Clotet B, Danta M, Journiac M, Matthews G, Meyer-Olson D, Nelson M, Schmidt R, Wedemeyer H]] , Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS 2011;25 (4):399-409 [PubMed]
[Contributors: Jonsson M, Fusco JS, Cole SR, Thomas JC, Porter K, Kaufman JS, Davidian M, White AD, Hartmann KE, Eron JJ Jr, del Amo J, Meyer L, Bucher HC, Chene G, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Lodi S, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Kaldor J, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Gill J, Jørgensen LB, Nielsen C, Pedersen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Hamouda O, Kücherer C, Bartmeyer B, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidou A, Rezza G, Dorrucci M, Balotta C, D'Arminio Monforte A, Cozzi-Lepri A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Bakken Kran AM, Rosinska M, Gniewosz J, Camacho R, Smolskaya T, Tor J, Garcia de Olalla P, Cayla J, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Brettle R, Delpech V, Lattimore S, Murphy G, Johnson A, Phillips A, Jaffe H, Morrison C, Salata R, Mugerwa R, Chipato T, Amornkul P]] , Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. ARCH INTERN MED 2011;171 (17):1560-1569 [PubMed]
Heiligenberg M, Michael KM, Kramer MA, Pawlita M, Prins M, Coutinho RA, Dukers-Muijrers NHTM, Waterboer T, Seroprevalence and Determinants of Eight High-Risk Human Papillomavirus Types in Homosexual Men, Heterosexual Men, and Women: A Population-Based Study in Amsterdam. SEX TRANSM DIS 2010;37 (11):672-680 [PubMed]
Maher L, White B, Hellard M, Madden A, Prins M, Kerr T, Page K, Candidate hepatitis C vaccine trials and people who inject drugs: Challenges and opportunities. VACCINE 2010;28 (45):7273-7278 [PubMed]
Rachinger A, Stolte IG, van de Ven TD, Burger JA, Prins M, Schuitemaker H, van 't Wout AB, Absence of HIV-1 Superinfection 1 Year after Infection between 1985 and 1997 Coincides with a Reduction in Sexual Risk Behavior in the Seroincident Amsterdam Cohort of Homosexual Men. CLIN INFECT DIS 2010;50 (9):1309-1315 [PubMed]
Steingrover R, Garcia EF, van Valkengoed IGM, Bekker V, Bezemer D, Kroon FP, Dekker L, Prins M, de Wolf F, Lange JMA, Prins JM, Transient Lowering of the Viral Set Point After Temporary Antiretroviral Therapy of Primary HIV Type 1 Infection. AIDS RES HUM RETROV 2010;26 (4):379-387 [PubMed]
van de Laar TJ, Matthews GV, Prins M, Danta M, Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010;24 (12):1799-1812 [PubMed]
van Houdt R, Bruisten SM, Geskus RB, Bakker M, Wolthers KC, Prins M, Coutinho RA, Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. J VIRAL HEPATITIS 2010;17 (2):108-114 [PubMed]
van Tuijn CFJ, Luitse JS, van der Valk M, van Wissen S, Prins M, Rosmulder R, Geerlings SE, Reduction of the door-to-needle time for administration of antibiotics in patients with a severe infection: a tailored intervention project. NETH J MED 2010;68 (3):123-127 [PubMed]
van Tuijn CFJ, Prins M, Luitse JS, Geerlings SE, Prognostic factors for important clinical outcomes in patients with a severe infection. INT J EMERG MED 2010;3 (4):293-298 [PubMed]
van Veen MG, Götz HM, van Leeuwen PA, Prins M, van de Laar MJW, HIV and sexual risk behavior among commercial sex workers in the Netherlands. ARCH SEX BEHAV 2010;39 (3):714-723 [PubMed]
Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chêne G, Mussini C, Porter K, Bucher HC [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Lodi S, Coughlin K, Walker S, Babiker A, Darbyshire J, de Luca A, Fisher M, Muga R, Kaldor J, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Gill J, Jørgensen LB, Nielsen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Chaix ML, Ghosn J, Boufassa F, Hamouda O, Kucherer C, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidoua A, Rezza G, Dorrucci M, Balotta C, D'Arminio Monforte A, Cozzi-Lepri A, van der Helm J, Geskus R, Schuitemaker H, Sannes M, Brubakk O, Eskild A, Bruun JN, Rosinska M, Gniewosz J, Camacho R, Smolskaya T, Tor J, de Olalla PG, Cayla J, del Romero J, Pérez-Hoyos S, Rickenbach M, Francioli P, Malyuta R, Brettle R, Delpech V, Lattimore S, Murphy G, Parry J, Gill N, Lee C, Johnson A, Phillips A, Jaffe H]] , Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies. PLOS MED 2010;7 (2):e1000239 [PubMed]
Xiridou M, van Veen M, Coutinho R, Prins M, Can migrants from high-endemic countries cause new HIV outbreaks among heterosexuals in low-endemic countries?. AIDS 2010;24 (13):2081-2088 [PubMed]
Zuure F, Davidovich U, Kok G, Depla AC, Hoebe C, van den Hoek A, Jansen PL, van Leeuwen-Gilbert P, Weegink CJ, Coutinho RA, Prins M, Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population. EUROSURVEILLANCE 2010;15 (15):5 19539-13 [PubMed]
Bezemer DO. Impact of antiretroviral therapy on HIV-1 transmission dynamics. s.l.: s.n.; 2009. 119p. ISBN 9789080641594 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Coutinho RA, Sabelis MW; copromotor(s): Prins M, de Wolf F)
Bohlius J, Schmidlin K, Costagliola D, Fätkenheuer G, May M, Caro Murillo AM, Mocroft A, Bonnet F, Clifford G, Touloumi G, Miro JM, Chene G, Lundgren J, Egger M [Contributors: Antinori A, Bonnet F, Boué F, Brockmeyer N, Casabona J, Lopez-Guillermo A, Ribera JM, Costagliola D, Dronda F, Obel N, Fätkenheuer G, Fisher M, Franceschi S, Gibb D, Le Moing V, Mocroft A, Nadal D, Touloumi G, Prins M, Raffi F, Roca B, Verbon A, Wolf T, Fortuny C, Bohlius J, Chakraborty R, Clifford G, Egger M, May M, Minder C, Sterne J, Zwahlen M, Ellefson M, Kjaer J, Collin F, Colin C]] , Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. AIDS 2009;23 (15):2029-2037 [PubMed]
Brown AE, Gifford RJ, Clewley JP, Kucherer C, Masquelier B, Porter K, Balotta C, Back NKT, Jorgensen LB, de Mendoza C, Bhaskaran K, Gill ON, Johnson AM, Pillay D [Contributors: del Amo J, Meyer L, Bucher H, Chene G, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Lodi S, Walker S, Babiker A, Darbyshire J, de Luca A, Fisher M, Muga R, Kaldor J, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Gill J, Jorgensen LB, Nielsen C, Pedersen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Boufassa F, Hamouda O, Kucherer C, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidou A, Rezza G, Dorrucci M, Longo B, Balotta C, van Asten L, van der Bij A, Geskus R, Coutinho R, Sannes M, Brubakk O, Eskild A, Bruun JN, Camacho R, Smolskaya T, Garcia de Olalla P, del Romero J, Perez-Hoyos S, Hernandez Aguado I, Rickenbach M, Francioli P, Malyuta R, Brettle R, Delpech V, Lattimore S, Murphy G, Parry J, Gill N, Lee C, Johnson A, Phillips A, Jaffe H]] , Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions. J INFECT DIS 2009;199 (3):427-431 [PubMed]
Buster MCA, Witteveen E, Prins M, van Ameijden EJC, Schippers G, Krol A, Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study. EUR ADDICT RES 2009;15 (4):179-187 [PubMed]
Cornelissen M, Hoogland FM, Back NK, Jurriaans S, Zorgdrager F, Bakker M, Brinkman K, Prins M, van der Kuyl AC, Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands. AIDS 2009;23 (12):1495-1500 [PubMed]
de Bruijne J, Schinkel J, Prins M, Koekkoek SM, Aronson SJ, van Ballegooijen MW, Reesink HW, Molenkamp R, van de Laar TJW, Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J CLIN MICROBIOL 2009;47 (12):3832-3838 [PubMed]
Heijman RLJ, Stolte IG, Thiesbrummel HFJ, van Leent E, Coutinho RA, Fennema JSA, Prins M, Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic. SEX TRANSM INFECT 2009;85 (4):249-255 [PubMed]
Lindenburg CEA, Weegink CJ, Verbon A, Prins M, Hoogenboezem GE. Richtsnoer Organisatie rond de behandeling van een chronische HCV-infectie bij (actieve injecterende) drugsgebruikers. Alphen aan den Rijn: Van Zuiden Communications B.V.; 2009. 39p. ISBN 978-90-8523-187-5
Marin B, Thiébaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, Hamouda O, Prins M, Walker S, Porter K, Sabin C, Chêne G, Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS 2009;23 (13):1743-1753 [PubMed]
Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, Prins M, Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009;23 (12):F1-F7 [PubMed]
van de Laar TJW, Molenkamp R, van den Berg C, Schinkel J, Beld MGHM, Prins M, Coutinho RA, Bruisten SM, Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J HEPATOL 2009;51 (4):667-674 [PubMed]
van den Berg CHSB. Hepatitus C virus. Epidemiology and immunology. s.l.: s.n.; 2009. 231p. ISBN 9789052788432 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Coutinho RA; copromotor(s): Prins M)
van den Berg CHSB, van de laar TJW, Kok A, Zuure FR, Coutinho RA, Prins M, Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J VIRAL HEPATITIS 2009;16 (8):568-577 [PubMed]
van der Wal WM, Prins M, Lumbreras B, Geskus RB, A simple G-computation algorithm to quantify the causal effect of a secondary illness on the progression of a chronic disease. STAT MED 2009;28 (18):2325-2337 [PubMed]
van Houdt R, van den Berg CHSB, Stolte IG, Bruisten SM, Dukers NHTM, Bakker M, Wolthers KC, Prins M, Coutinho RA, Two Decades of Hepatitis B Infections Among Drug Users in Amsterdam: Are They Still a High-Risk Group?. J MED VIROL 2009;81 (7):1163-1169 [PubMed]
van Veen MG, Kramer MA, Op de Coul ELM, van Leeuwen AP, de Zwart O, van de Laar MJW, Coutinho RA, Prins M, Disassortative sexual mixing among migrant populations in The Netherlands: a potential for HIV/STI transmission?. AIDS CARE 2009;21 (6):683-691 [PubMed]
[Contributors: Bohlius J, Schmidlin K, Costagliola D, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Karafoulidou A, Miro JM, Lundgren J, Chene G, Egger M, Antinori A, Boué F, Brockmeyer N, Casabona J, Dronda F, Obel N, Fisher M, Franceschi S, Gibb D, Le Moing V, Nadal D, Touloumi G, Prins M, Raffi F, Roca B, Verbon A, Wolf T, Fortuny C, Chakraborty R, Minder C, Sterne J, Zwahlen M, Ellefson M, Kjaer J, Collin F, Colin C, Weller I, Ledergerber B, Warszawski J, Meyer L, Dabis F, Krause MM, Goujard C, Leport C, de Wolf F, Reiss P, Porter K, Dorrucci M, Sabin C, del Amo J, Thorne C, Kirk O, Staszewski S, Perez-Hoyos S, Almeda J, D'Arminio Monforte A, de Martino M, Ramos J, Battegay M, Mussini C, Tookey P, Castagna A, de Wit S, Torti C, Teira R, Garrido M, Dedes N, Phillips A, Furrer H, Newell ML, Telenti A, Pantazis N, Lechenadec J, Jérôme F, Tran L, Balestre E, Lanoy E, Couturier F, Rispens T, Gras LAJ, Bhaskaran K, Hill T, Judd A, Duong T, Sobrino P, Jennings B, Pérez-Hoyos S, Bonfigli S, Cozzi-Lepri A, Corvasce S, Adorni F, Ridolfo AL, Paraninfo G, Ramos JT, Keiser O, Borghi V, Masters J, Ortiga B, Salpietro S, Rickenbach M, Poll B]] , Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. ANTIVIR THER 2009;14 (8):1065-1074 [PubMed]
Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Prins M, Geskus RB, Gras L, Coutinho RA, Fraser C, A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008;22 (9):1071-1077 [PubMed]
Bezemer D, van Sighem A, de Wolf F, Cornelissen M, van der Kuyl AC, Jurriaans S, van der Hoek L, Prins M, Coutinho RA, Lukashov VV, Combination antiretroviral therapy failure and HIV super-infection. AIDS 2008;22 (2):309-311 [PubMed]
Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K [Contributors: del Amo J, Meyer L, Bucher H, Chêne G, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Bhaskaran K, Walker S, Babiker A, Darbyshire J, de Luca A, Fisher M, Muga R, Kaldor J, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Gill J, Jørgensen LB, Nielsen C, Pedersen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Boufassa F, Hamouda O, Kucherer C, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidou A, Rezza G, Dorrucci M, Longo B, Balotta C, van Asten L, van der Bij A, Geskus R, Coutinho R, Sannes M, Brubakk O, Eskild A, Bruun JN, Rosinska M, Camacho R, Smolskaya T, Garcia de Olalla P, del Romero J, Pérez-Hoyos S, Hernandez Aguado I, Rickenbach M, Francioli P, Malyuta R, Brettle R, Delpech V, Lattimore S, Murphy G, Parry J, Gill N, Lee C, Johnson A, Phillips A, Jaffe H]] , Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA-J AM MED ASSOC 2008;300 (1):51-59 [PubMed]
de Vries HJC, van der Bij AK, Fennema JSA, Smit C, de Wolf F, Prins M, Coutinho RA, Morré SA, Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. SEX TRANSM DIS 2008;35 (2):203-208 [PubMed]
Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, Hernández-Aguado I, Meyer L, Porter K, del Amo J [Contributors: del Amo J, Meyer L, Bucher H, Chêne G, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Bhaskaran K, Walker S, Babiker A, Darbyshire J, de Luca A, Fisher M, Goujard C, Muga R, Kaldor J, Kelleher T, Gelgor L, Ramacciotti T, Cooper D, Smith D, Gill J, Jørgensen LB, Nielsen C, Pedersen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Vanhems P, Boufassa F, Hamouda O, Kucherer C, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidou A, Rezza G, Dorrucci M, Longo B, Balotta C, van Asten L, van der Bij A, Geskus R, Coutinho R, Sannes M, Brubakk O, Eskild A, Bruun JN, Rosinska M, Camacho R, Smolskaya T, Tor J, de Olalla PG, Caylà J, del Romero J, Pérez-Hoyos S, Aguado IH, Belda J, Rickenbach M, Francioli P, Malyuta R, Brettle R, Delpech V, Lattimore S, Murphy G, Parry J, Gill N, Lee C, Johnson A, Phillips A, Jaffe H]] , Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. AM J EPIDEMIOL 2008;168 (5):532-540 [PubMed]
Kramer MA, van Veen MG, Op de Coul ELM, Geskus RB, Coutinho RA, van de Laar MJW, Prins M, Migrants travelling to their country of origin: a bridge population for HIV transmission?. SEX TRANSM INFECT 2008;84 (7):554-555 [PubMed]
Pantazis N, Touloumi G, Vanhems P, Gill J, Bucher HC, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Lodi S, Walker S, Babiker A, Darbyshire J, Bucher H, de Luca A, Fisher M, Muga R, Kaldor J, Kelleher T, Ramacciotti T, Gelgor L, Cooper D, Smith D, Gill J, Jørgensen LB, Nielsen C, Pedersen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Boufassa F, Hamouda O, Kucherer C, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidou A, Rezza G, Dorrucci M, Longo B, Balotta C, van Asten L, van der Bij A, Geskus R, Coutinho R, Sannes M, Brubakk O, Eskild A, Bruun JN, Rosinska M, Camacho R, Smolskaya T, de Olalla PG, del Romero J, Pérez-Hoyos S, Aguado IH, Rickenbach M, Francioli P, Malyuta R, Brettle R, Delpech V, Lattimore S, Murphy G, Parry J, Gill N, Lee C, Johnson A, Phillips A, Jaffe H]] , The effect of antiretroviral treatment of different durations in primary HIV infection. AIDS 2008;22 (18):2441-2450 [PubMed]
Roede BM, Bresser P, Bindels PJE, Kok A, Prins M, ter Riet G, Geskus RB, Herings RMC, Prins JM, Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. THORAX 2008;63 (11):968-973 [PubMed]
Ruys TA, Nanlohy NM, van den Berg CHSB, Hassink E, Beld M, van de Laar T, Bruisten S, Wit F, Krol A, Prins M, Lange J, van Baarle D, HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance. J VIRAL HEPATITIS 2008;15 (6):409-420 [PubMed]
Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M, Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study. JAIDS-J ACQ IMM DEF 2008;47 (2):221-225 [PubMed]
Touloumi G, Pantazis N, Stirnadel HA, Walker AS, Boufassa F, Vanhems P, Porter K [Contributors: del Amo J, Meyer L, Bucher HC, Chêne G, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Lodi S, Walker S, Babiker A, Darbyshire J, Bucher HC, de Luca A, Fisher M, Goujard C, Muga R, Kaldor J, Kelleher T, Gelgor L, Ramacciotti T, Cooper D, Smith D, Gill J, Jørgensen LB, Nielsen C, Pedersen C, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Boufassa F, Hamouda O, Kucherer C, Pantazis N, Hatzakis A, Paraskevis D, Karafoulidou A, Rezza G, Dorrucci M, Longo B, Balotta C, van Asten L, van der Bij A, Geskus R, Coutinho R, Sannes M, Brubakk O, Eskild A, Bruun JN, Rosinska M, Camacho R, Smolskaya T, Garcia de Olalla P, del Romero J, Pérez-Hoyos S, Aguado IH, Rickenbach M, Francioli P, Malyuta R, Brettle R, Delpech V, Lattimore S, Murphy G, Parry J, Gill N, Lee C, Johnson A, Phillips A, Jaffe H]] , Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice. JAIDS-J ACQ IMM DEF 2008;49 (5):492-498 [PubMed]
van de laar TJW. Molecular epidemiology of hepatitis-C virus. s.l.: s.n.; 2008. 176p. ISBN 9789071382611 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Coutinho RA; copromotor(s): Bruisten SM, Prins M)
van de Laar TJW, Urbanus AT, Bruisten SM, de Vries HJC, Thiesbrummel HFJ, Coutinho RA, Prins M, Sexual transmission of hepatitis c in MSM may not be confined to those with HIV infection - Reply. J INFECT DIS 2008;197 (8):1214-1215 [PubMed]
Dukers NHTM, Fennema HSA, van der Snoek EM, Krol A, Geskus RB, Pospiech M, Jurriaans S, van der Meijden WI, Coutinho RA, Prins M, HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984-2005. AIDS 2007;21 (4):491-499 [PubMed]
Geskus RB, Prins M, Hubert JB, Miedema F, Berkhout B, Rouzioux C, Delfraissy JF, Meyer L, The HIV RNA setpoint theory revisited. RETROVIROLOGY 2007;4:65 [PubMed]
Ghys PD, Zaba B, Prins M, Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network. AIDS 2007;21 (Suppl. 6):S1-S4 [PubMed]
Kok A, Zuure FR, Weegink CJ, Coutinho RA, Prins M, Hepatitis C in Nederland: schaarse gegevens over actuele prevalentie en de noodzaak van epidemiologisch onderzoek en innovatieve opsporingsmethoden. NED TIJDSCHR GENEESKD 2007;151 (43):2367-2371 [PubMed]
van de Laar TJW, van der Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, van der Meer JTM, de Vries HJC, Mulder JW, van Agtmael M, Jurriaans S, Wolthers KC, Coutinho RA, Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J INFECT DIS 2007;196 (2):230-238 [PubMed]
van den Berg CHSB, Smit C, Bakker M, Geskus RB, Berkhout B, Jurriaans S, Coutinho RA, Wolthers KC, Prins M, Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. EUR J EPIDEMIOL 2007;22 (3):183-193 [PubMed]
van den Berg C, Smit C, van Brussel G, Coutinho R, Prins M, Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. ADDICTION 2007;102 (9):1454-1462 [PubMed]
van der Bij AK, Kolader ME, de Vries HJC, Prins M, Coutinho RA, Dukers NHTM, Condom use rather than serosorting explains differences in HIV incidence among men who have sex with men. JAIDS-J ACQ IMM DEF 2007;45 (5):574-580 [PubMed]
Witteveen E, van Ameijden EJC, Prins M, Schippers GM, Factors associated with the initiation of cocaine and heroin among problem drug users: reflections on interventions. SUBST USE MISUSE 2007;42 (6):933-947 [PubMed]
Witteveen E, van Ameijden EJC, Prins M, Schippers GM, Unmet needs and barriers to health care use for young adult, problematic drug users: an exploratory study. SUCHT 2007;53 (3):169-176
Bezemer D, de Ronde A, Prins M, Porter K, Gifford R, Pillay D, Masquelier B, Fleury H, Dabis F, Back N, Jurriaans S, van der Hoek L, Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load. ANTIVIR THER 2006;11 (2):173-178 [PubMed]
Klazinga N, Prins M, Verhoeff A, Stronks K, van der Poll T, De academische werkkplaats GGD/AMC in Amsterdam. TIJDSCHR GEZONDHEIDSWET 2006;84 (4):199-200
Krol A, Lensen R, Veenstra J, Prins M, Schuitemaker H, Coutinho RA, Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men. EUR J EPIDEMIOL 2006;21 (6):469-473 [PubMed]
Lindenburg CEA, Krol A, Smit C, Buster MCA, Coutinho RA, Prins M, Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS 2006;20 (13):1771-1775 [PubMed]
Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, Dabis F, Gifford R, Nielsen C, Pedersen C, Balotta C, Rezza G, Ortiz M, de Mendoza C, Kücherer C, Poggensee G, Gill J, Porter K, The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS 2006;20 (1):21-28 [PubMed]
Shao W, Lazaryan A, Dorak MT, Penman-Aguilar A, Wilson CM, Margolick JB, Goedert JJ, Prins M, Tang J, Kaslow RA, Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression. AIDS 2006;20 (12):1583-1590 [PubMed]
Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K, Prins M, Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006;20 (5):741-749 [PubMed]
Smit C, Lindenburg K, Geskus RB, Brinkman K, Coutinho RA, Prins M, Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour. ADDICTION 2006;101 (3):433-440 [PubMed]
Thiébaut R, Jacqmin-Gadda H, Walker S, Sabin C, Prins M, del Amo J, Porter K, Dabis F, Chêne G, Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversion. HIV MED 2006;7 (1):1-9 [PubMed]
Geskus RB, Meyer L, Hubert JB, Schuitemaker H, Berkhout B, Rouzioux C, Theodorou ID, Delfraissy JF, Prins M, Coutinho RA, Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development. JAIDS-J ACQ IMM DEF 2005;39 (3):321-326 [PubMed]
Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, Miedema F, Schuitemaker H, Low-level CD4(+) T cell activation is associated with low susceptibility to HIV-1 infection. J IMMUNOL 2005;175 (9):6117-6122 [PubMed]
Kramer MA, van den Hoek A, Coutinho RA, Prins M, Sexual risk behaviour among Surinamese and Antillean migrants travelling to their countries of origin. SEX TRANSM INFECT 2005;81 (6):508-510 [PubMed]
Madec Y, Boufassa F, Porter K, Meyer L, Study group members AMC -, van Asten LCHI, van der Bij A, Geskus RB, Prins M, Coutinho RA, Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters: the CASCADE Collaboration. AIDS 2005;19 (17):2001-2007 [PubMed]
Masquelier B, Bhaskaran K, Pillay D, Gifford R, Balestre E, Jørgensen LB, Pedersen C, van der Hoek L, Prins M, Balotta C, Longo B, Kücherer C, Poggensee G, Ortiz M, de Mendoza C, Gill J, Fleury H, Porter K, Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms - Data from seroconverters in the CASCADE collaboration from 1987 to 2003. JAIDS-J ACQ IMM DEF 2005;40 (5):505-511 [PubMed]
Prins M, Meyer L, Hessol NA, Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS 2005;19 (4):357-370 [PubMed]
Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJC, Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users. DRUG ALCOHOL DEPEN 2005;79 (2):231-240 [PubMed]
Termorshuizen F, Krol A, Prins M, van Ameijden EJC, Long-term outcome of chronic drug use: the Amsterdam Cohort Study among Drug Users. AM J EPIDEMIOL 2005;161 (3):271-279 [PubMed]
Thiébaut R, Jacqmin-Gadda H, Babiker A, Commenges D [Contributors: van Asten LCHI, Prins M, Coutinho RA, et al -]] , Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection. STAT MED 2005;24 (1):65-82 [PubMed]
van Asten LCHI. Epidemiological studies among injecting drug users infected with HIV. Highly active antiretroviral therapy . Tuberculosis Hepatitis C Immunology. S.l.: s.n.; 2005. 111p. ISBN 9789090198385 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Coutinho RA; copromotor(s): Prins M)
van Asten L, Zangerle R, Hernández Aguado I, Boufassa F, Broers B, Brettle RP, Roy Robertson J, McMenamin J, Coutinho RA, Prins M, Do HIV disease progression and HAART response vary among injecting drug users in Europe?. EUR J EPIDEMIOL 2005;20 (9):795-804 [PubMed]
van Benthem BHB, Vernazza P, Coutinho RA, Prins M, Impact of pregnancy and menopause on CD4 cell counts. JAIDS-J ACQ IMM DEF 2005;38 (Suppl. 1):S22 [PubMed]
van de Laar TJW, Langendam MW, Bruisten SM, Welp EAE, Verhaest I, van Ameijden EJC, Coutinho RA, Prins M, Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands. J MED VIROL 2005;77 (4):509-518 [PubMed]
van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JMA, Coutinho RA, Schuitemaker H, GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J INFECT DIS 2005;191 (5):678-685 [PubMed]
van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JMA, Coutinho RA, Schuitemaker H, GB virus C infection and survival in the Amsterdam Cohort study - Reply to George and to Stapleton et al. J INFECT DIS 2005;191 (12):2158-2160
Bezemer D, Jurriaans S, Prins M, van der Hoek L, Prins JM, de Wolf F, Berkhout B, Coutinho R, Back NKT, Declining trend in transmission of drug-resistant HIV-1 in Amsterdam. AIDS 2004;18 (11):1571-1577 [PubMed]
Bhaskaran K, Brettle R, Porter K, Walker AS [Contributors: van Asten LCHI, van Benthem BHB, Prins M, Coutinho RA, et al -]] , Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors. AIDS 2004;18 (4):673-681 [PubMed]
Bruisten SM, van Asten LCHI, van der Laar T, Prins M, Changes in the prevalence of hepatitis C virus genotype among injection drug users: a highly dynamic process - Reply : letter. J INFECT DIS 2004;190 (6):1200-1201
Dukers NHTM, Prins M, Coutinho RA, An update on HIV related epidemiological research. EUR J EPIDEMIOL 2004;19 (6):509-511 [PubMed]
Koning FA, Jansen CA, Dekker J, Kaslow RA, Dukers N, van Baarle D, Prins M, Schuitemaker H, Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour. AIDS 2004;18 (8):1117-1126 [PubMed]
Smit C, Geskus R, Uitenbroek D, Mulder D, van den Hoek A, Coutinho RA, Prins M, Declining AIDS mortality in Amsterdam - Contributions of declining HIV incidence and effective therapy. EPIDEMIOLOGY 2004;15 (5):536-542 [PubMed]
Touloumi G, Pantazis N, Babiker AG, Walker SA, Katsarou O, Karafoulidou A, Hatzakis A, Porter K [Contributors: van Asten L, van Benthem B, Prins M, Coutinho R]] , Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS 2004;18 (12):1697-1705 [PubMed]
van Asten L, Danisman F, Otto SA, Borghans JAM, Hazenberg MD, Coutinho RA, Prins M, Miedema F, Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection. AIDS 2004;18 (14):1885-1893 [PubMed]
van Asten L, Prins M, Infection with concurrent multiple hepatitis C virus genotypes is associated with faster HIV disease progression. AIDS 2004;18 (17):2319-2324 [PubMed]
van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S, Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis. J INFECT DIS 2004;189 (2):292-302 [PubMed]
van der Bij AK, Prins M, Geskus RG, Response to 'GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality' by Bjorkman et al. AIDS 2004;18 (17):2344-5; author reply 2345-6 [PubMed]
Babiker A, Darbyshire J, Pezzotti P, Porter K, Prins M, Sabin C, Walker AS, Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters. JAIDS-J ACQ IMM DEF 2003;32 (3):303-310 [PubMed]
CASCADE -, van Asten LCHI, van Benthem BHB, Prins M, Coutinho RA, Estimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data. HIV MED 2003;4 (4):332-337
CASCADE -, van Benthem BHB, Prins M, Coutinho RA, Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion. JAIDS-J ACQ IMM DEF 2003;33:184-190 [PubMed]
Hazenberg MD, Otto SA, van Benthem BHB, Roos MTL, Coutinho RA, Lange JMA, Hamann D, Prins M, Miedema F, Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003;17 (13):1881-1888 [PubMed]
Op de Coul EL, Beuker RJ, Prins M, Fennema JS, van der Meijden WI, Coutinho RA, van de Laar MJ, HIV-infectie en aids in Nederland: prevalentie en incidentie, 1987-2001. NED TIJDSCHR GENEESKD 2003;147 (22):1071-1076 [PubMed]
Op de Coul ELM, Fennema JSA, van den Hoek JAR, Prins M, Thio B, van Valkengoed IGM, de Wolf F, van de Laar MJW. HIV-infecties en aids in Nederland: prevalentie en incidentie, 1987-2002 in: Capita selecta HIIV/AIDS 2003. Alphen aan de Rijn: Van Zuiden Communications B.V.; 2003., p. 1-9
Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Walker AS [Contributors: van Asten LCHI, van Benthem BHB, Prins M, Coutinho RA, et al -]] , Determinants of survival following HIV-1 seroconversion after the introduction of HAART. LANCET 2003;362 (9392):1267-1274 [PubMed]
van Asten LC, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Hernández Aguado I, McMenamin J, Zangerle R, Fontanet A, Coutinho RA, Prins M, Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level. EUR J PUBLIC HEALTH 2003;13 (4):347-349 [PubMed]
van Asten L, Langendam M, Zangerle R, Hernández Aguado I, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Fontanet A, Coutinho RA, Prins M, Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion. AIDS 2003;17 (8):1201-1208 [PubMed]
van Rij RP, Hazenberg MD, van Benthem BHB, Otto SA, Prins M, Miedema F, Schuitemaker H, Early viral load and CD4(+) T cell count, but not percentage of CCR5(+) or CXCR4(+) CD4(+) T cells, are associated with R5-to-X4 HIV type 1 virus evolution. AIDS RES HUM RETROV 2003;19 (5):389-398 [PubMed]
Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O, Brettle R, del Romero J, Prins M, van Benthem B, Kirk O, Pederson C, Hernández Aguado I, Pérez-Hoyos S, Eskild A, Bruun JN, Sannes M, Sabin C, Johnson AM, Phillips AN, Francioli P, Vanhems P, Egger M, Rickenbach M, Cooper D, Kaldor J, Ashton L, Vizzard J, Muga R, Day NE, de Angelis D, Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. INT J EPIDEMIOL 2002;31 (5):951-958 [PubMed]
Prins M, van Asten LCH, Stolte IG, Dukers NHTM, Coutinho RA, De 14e Internationale Aidsconferentie: 'Kennis, betrokkenheid en actie'. NED TIJDSCHR GENEESKD 2002;146 (40):1899-1903 [PubMed]
Renwick N, Dukers NHTM, Weverling GJ, Sheldon JA, Schulz TF, Prins M, Coutinho RA, Goudsmit J, Risk factors for human herpesvirus 8 infection in a cohort of drug users in The Netherlands, 1985-1996. J INFECT DIS 2002;185 (12):1808-1812 [PubMed]
van Benthem BHB, Vernazza P, Coutinho RA, Prins M, The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS 2002;16 (6):919-924 [PubMed]
van der Vliet HJJ, von Blomberg BME, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van den Eertwegh AJM, Giaccone G, Miedema F, Scheper RJ, Pinedo HM, Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J IMMUNOL 2002;168 (3):1490-1495 [PubMed]
Dukers NH, Goudsmit J, de Wit JB, Prins M, Weverling GJ, Coutinho RA, Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS 2001;15 (3):369-378 [PubMed]
Op de Coul EL, Prins M, Cornelissen M, van der Schoot A, Boufassa F, Brettle RP, Hernández-Aguado L, Schiffer V, McMenamin J, Rezza G, Robertson R, Zangerle R, Goudsmit J, Coutinho RA, Lukashov VV, Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. AIDS 2001;15 (2):257-266 [PubMed]
Prins M, Geskus RB, Coutinho RA, Dwalingen in de methodologie. XXXV. Bias in het prevalentiecohort-onderzoek naar het natuurlijke ziektebeloop. NED TIJDSCHR GENEESKD 2001;145 (45):2170-2172 [PubMed]
[Contributors: Coutinho RA, Prins M, van Benthem B, et al -]] , Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?. JAIDS-J ACQ IMM DEF 2001;28:158-165 [PubMed]
Dukers NH, Renwick N, Prins M, Geskus RB, Schulz TF, Weverling GJ, Coutinho RA, Goudsmit J, Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. AM J EPIDEMIOL 2000;151 (3):213-224 [PubMed]
Prins M, Sabin CA, Lee CA, Devereux H, Coutinho RA, Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men. AIDS 2000;14 (12):1829-1837 [PubMed]
Meyer L, Magierowska M, Hubert JB, Theodorou I, van Rij R, Prins M, de Roda Husman AM, Coutinho R, Schuitemaker H, CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. SEROCO Cohort. Amsterdam Cohort Studies on AIDS. AIDS 1999;13 (5):624-626 [PubMed]
Prins M, Brettle RP, Robertson JR, Hernández Aguado I, Broers B, Carré N, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A, Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?. INT J EPIDEMIOL 1999;28 (3):541-549 [PubMed]
Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A, Do gender differences in CD4 cell counts matter?. AIDS 1999;13 (17):2361-2364 [PubMed]
Roos MT, Prins M, Koot M, de Wolf F, Bakker M, Coutinho RA, Miedema F, Schellekens PT, Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS. AIDS 1998;12 (14):1745-1751 [PubMed]
de Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, Broersen SM, Bakker M, Roos MT, Prins M, de Wolf F, Coutinho RA, Miedema F, Goudsmit J, Schuitemaker H, Association between CCR5 genotype and the clinical course of HIV-1 infection. ANN INTERN MED 1997;127 (10):882-890 [PubMed]
Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, de Wolf F, Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men. AIDS 1997;11 (11):1383-1388 [PubMed]
Coutinho RA, Prins M, Spijkerman IJ, Geskus RB, Keet RP, Fennema HS, Strathdee SA, Summary of track C: epidemiology and public health. AIDS 1996;10 (Suppl. 3):S115-S121 [PubMed]
Key publications

van der Helm J, Geskus R, Sabin C, Meyer L, del Amo J, Chene G, Dorrucci M, Muga R, Porter K, Prins M [Contributors: del Amo J, Meyer L, Bucher HC, Chene G, Hamouda O, Pillay D, Prins M, Rosinska M, Sabin C, Touloumi G, Porter K, Olson A, Coughlin K, Walker S, Babiker A, de Luca A, Fisher M, Muga R, Zangerle R, Kelleher T, Cooper D, Grey P, Finlayson R, Bloch M, Ramacciotti T, Gelgor L, Smith D, Gill J, Lutsar I, Dabis F, Thiebaut R, Masquelier B, Costagliola D, Guiguet M, Vanhems P, Ghosn J, Boufassa F, Kuecherer C, Bartmeyer B, Paparizos V, Gargalianos-Kakolyris P, Lazanas M, Pantazis N, Katsarou O, Dorrucci M, D'Arminio Monforte A, Geskus R, van der Helm J, Schuitemaker H, Sannes M, Brubakk O, Kran AMB, Rosinska M, Tor J, de Olalla PG, Cayla J, Moreno S, Monge S, del Romero J, Rickenbach M, Francioli P, Malyuta R, Murphy G, Johnson A, Phillips A, Salata R, Mugerwa R, Chipato T, Amornkul PN, Gilmour J, Kamali A, Karita E, Chaix ML, Rezza G]] , Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. GASTROENTEROLOGY 2013;144 (4):751-760.e2 [PubMed]
Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M [Contributors: Page K, Bruneau J, Cox AL, Dore GJ, Grebely J, Hellard M, Lauer G, Kim AY, Lloyd AR, Maher L, McGovern BH, Prins M, Shoukry NH, Morris M, Hahn J, Rice TM, Rilla M, Alavi M, Bouchard R, Evans J, Grady B, Aneja J, Sacks-Davis R, Teutsch S, White B, Wells B, Zang G, Applegate T, Matthews G, Yeung B, Schinkel J, Prince LE, Roy E, Bates A, Enriquez J, Chow S, McCredie L, Aitken C, Doyle J, Spelman T]] , The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. HEPATOLOGY 2014;59 (1):109-120 [PubMed]
Page K, Morris MD, Hahn JA, Maher L, Prins M, Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. CLIN INFECT DIS 2013;57 (Suppl. 2):S32-S38 [PubMed]
Urbanus AT, van de Laar TJW, van den Hoek A, Zuure FR, Speksnijder AGCL, Baaten GGG, Heijman T, Vriend HJ, Op de Coul ELM, Coutinho RA, Prins M, Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?. J HEPATOL 2011;55 (6):1207-1214 [PubMed]
Urbanus AT, van de Laar TJW, Geskus R, Vanhommerig JW, van Rooijen MS, Schinkel J, Heijman T, Coutinho RA, Prins M, Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS 2014;28 (5):781-790 [PubMed]


All Publications

Research programmes

Epidemiology and Prevention of Infectious Diseases

Our research is embedded in the Infectious Diseases Department of the Public Health Service of Amsterdam (PHSA), through which we have access to key populations at risk of infection. Traditionally most of our studies were on HIV infection. In the past decade, research on other sexually transmitted and blood-borne infections has become an important component of our research program.

One of the most significant research successes is a set of prospective studies in the Amsterdam Cohort Studies (www.amsterdamcohortstudies.or) on HIV among men who have sex with men (MSM) and people who use drugs. These cohorts began in 1984 and are a collaboration between AMC, PHSA, SHM and Sanquin. The majority of the participants are followed at the PHSA. Epidemiological, psycho-social, virological and immunological data of over 4400 persons have been collected and blood samples – taken every 3-6 months – have been stored. Over the past 30 years >100 PhD theses have been completed based on these data and this work has had significant impact on health policy in the Netherlands and internationally.

This strong expertise in cohort studies greatly contributed to the initiation of the AGEhIV cohort on comorbidity and aging, the MOSAIC cohort on acute HCV in MSM and the PrEP demonstration project (AMPrEP) among high risk HIV negative MSM in recent years.The AMPrEP project, initiated in 2015, evaluates the uptake, acceptability, and usability of  PrEP among HIV negative MSM and transgender people and is integrated in the routine care at  the STI clinic. We are the first health service in the Netherlands to offer PrEP, placing Amsterdam at the forefront of implementation research into PrEP in Europe. Routine data collected at our large STI clinic, Public Health laboratory and travel department are also used for research. We play an active role in the population–based multi-ethnic HELIUS cohort and in international studies.

Our studies focus on the epidemiology and prevention of HIV, viral hepatitis, STI, HPV and travel-related infections. We develop and evaluate off and online interventions. Our research is conducted at the city level, nationally and internationally. Our projects are funded by ZonMW, GGD, RIVM, Aidsfonds, EU and NIH grants. The research program is headed by Prof. Maria Prins. She and  Prof. Henry de Vries, Professor of Skin Infections at the AMC and staff member of the STI clinic of the PHSA, currently supervise 16 PhD students at the PHSA's infectious diseases department. Maria Prins is also heading the infectious diseases network of the Academic Collaborative for Public Health of PHSA , AMC: and stakeholders in the region the Sarphati Initiative (www.sarphati.nl), promoting research partnerships between policy, academic, and public health. The research group participates in CINIMA.
 

Faculty
Prof. dr. M. Prins (GGD Amsterdam)
Dr. R.B. Geskus PhD (Health Service of Amsterdam)
Prof. H.J.C. de Vries MD PhD (STI Outpatient Clinic, Public Health Service (GGD) Amsterdam and Centre for Infectious Diseases, (CIB/RIVM) Bilthoven, the Netherlands)

Postdocs
Dr. F.R. Zuure

PhD Students
J.P. Bil
W.P.H. van Bilsen
Drs. W. van den Boom
L.N. Coyer
M. Dijkstra
Drs. E. Hoornenborg MD (GGD)
S.H. Hulstein
Drs. F. Lambers
A.M. Newsum MD (GGD Amsterdam / Public Health Service of Amsterdam)
M.S. Ottevanger
F.W. Overbosch MD (Public Health Service Amsterdam)
T. Prinsenberg
Drs. D.K. van Santen PhD (GGD)
H.M.L. Zimmermann

Others
Dr. S.M. Bruisten PhD (GGD Amsterdam)
Dr. U. Davidovich (GGD)
Dr. A. Matser PhD (GGD Amsterdam)
Dr. M.F. Schim van der Loeff MD PhD (GGD Amsterdam)
Dr. G.J.B. Sonder MD (GGD)

Other research related activities
  • Membership of editorial board / Editorship, AIDS
Current research funding
  • Gemeente Amsterdam, GGD
  • Stichting Aidsfonds/SOA AIDS Nederland